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Vesicles are hollow spherical structures formed by the self-assembly of 
amphiphilic molecules in aqueous solution. They are of great interest for applications 
ranging from drug delivery and controlled release to separations and sensing. 
However, the limited stability of vesicles to external conditions such as pH, 
temperature or ionic strength has hampered their applicability. In this dissertation, we 
explore the integration of vesicles with biopolymers as a route to creating vesicle-
bearing soft materials with increased stability. Two specific types of such materials 
are studied: (a) vesicle gels, where the vesicles are linked into a network by 
biopolymer chains; and (b) vesicle-loaded capsules, where the vesicles are embedded 
in biopolymer-based capsules. The materials we have developed could be useful for 
the controlled and targeted release of drugs, cosmetics, and other chemicals.  
 
The first part of this dissertation focuses on vesicle gels, obtained by adding a 
hydrophobically-modified polysaccharide, chitosan (denoted as hm-chitosan) to a 
solution of surfactant vesicles. The resulting gel shows an elastic rheological 
response, and is able to hold its own weight upon tube inversion. Small-angle neutron 
  
scattering (SANS) and cryo-transmission electron microscopy (cryo-TEM) are used 
to confirm the existence of vesicles within the gel. Based on these results, the likely 
structure in these gels is a network of vesicles connected by hm-chitosan chains, with 
the hydrophobes on the polymer embedded in vesicle bilayers. The SANS and cryo-
TEM data also reveal interesting differences in the morphology of the vesicles at low 
and high polymer concentrations. In particular, adding a high concentration of 
polymer to unilamellar vesicles is shown to transform some of these into bilamellar 
(double-bilayered) structures. A similar co-existence of unilamellar and bilamellar 
vesicles is observed in all eukaryotic cells, but this is the first systematic 
demonstration of the phenomenon in an in vitro formulation.      
 
The final part of this dissertation focuses on vesicle-loaded capsules. 
Capsules are created spontaneously when a solution of a cationic biopolymer is added 
dropwise into a solution of an anionic biopolymer. The driving force for capsule 
formation is the electrostatic interaction between the biopolymers at the interface of 
the drop. We modify the above procedure to create capsules with embedded vesicles. 
Additionally, to demonstrate the potential use of these capsules in targeted drug 
delivery, we load them with magnetic nanoparticles, and attach antibodies to the 
capsule surface. Controlled release experiments are conducted with both the vesicle-
bearing capsules and with the vesicle gels. In each case, a model dye encapsulated in 
the vesicles is shown to release slowly over an extended period of time due to the 
combination of transport resistances from the vesicle bilayer and the capsule/gel. The 
results indicate the potential utility of these materials for drug delivery applications. 
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Introduction And Overview 
 
1.1. Problem Description and Motivation 
This dissertation revolves around the theme of vesicles. Vesicles are hollow 
spherical structures formed by the self-assembly of surfactants, lipids, or block 
copolymers in aqueous solution.1-3 They have long been a scientific curiosity because 
of their structural resemblance to primitive biological cells (see Chapter 2 for a 
detailed description). From a technological standpoint, vesicles have attracted a great 
deal of interest for applications ranging from drug delivery and controlled release to 
separations and sensing.1   
 
Although the potential of vesicles has been well recognized, especially for 
drug delivery, this has not translated into a wide range of commercial applications 
yet.4 The underlying reason for this is the limited stability of vesicles to external 
perturbations caused by pH, temperature, ionic strength or chemical species. For 
example, in the context of drug delivery, the sensitivity of vesicles to environmental 
variables causes drug encapsulated in the vesicles to be released too rapidly, or at 




A related challenge in drug delivery is the need to deliver toxic drugs directly 
to a target site and nowhere else. This is particularly important in cancer therapy, 
where chemotherapeutic drug therapy ends up killing healthy cells along with the 
tumor cells. A preferred alternative would be to deliver drug specifically to the tumor 
cells alone, thereby minimizing side effects and maximizing the efficacy of the drug.5 
Towards this end, the idea of attaching tumor-specific ligands or antibodies to 
vesicles has been widely explored.6,7 However, here again, the relative fragility of 
vesicles complicates the antibody attachment step. The underlying reason for these 
problems with vesicles is that they are self-assembled structures, held by weak 
physical bonds rather than stronger covalent or ionic bonds. 
 
1.2. Proposed Approach 
To overcome the above shortcomings of vesicles, a number of approaches 
have been investigated. For example, new lipids have been synthesized whose 
bilayers can be stabilized by polymerization. Synthetic polymers, such as 
polyethylene glycol (PEG) have been tethered to the bilayers of vesicles, and such 
“PEGylated vesicles” have been shown to have a longer circulation time in an 
organism compared to conventional vesicles.8,9   
 
In this dissertation, we explore the integration of polymers with vesicles as a 
route to creating new and useful classes of soft materials. We focus on systems where 
the polymer plays an active role in creating a carrier or matrix for the vesicles. The 




Two specific classes of such materials are investigated, and these are depicted in 
Figure 1.1 and briefly described below. 
 
1.2.1. Vesicle Gels Anchored by Biopolymers 
The first concept investigated is that of “vesicle gels”, which consist of a 
network of vesicles linked by polymer chains (Figure 1.1a).10-14 That is, the vesicles 
form the nodes or junction points in a polymer network, and such a material behaves 
as a soft, elastic solid (see photograph in Figure 1.1a). The immobilization of vesicles 
Figure 1.1.  Schematic illustrations of the two types of materials investigated in this





enhances their stability to external perturbation. To create such a structure, we add a 
hydrophobically-modified water-soluble polymer (such polymers are referred to as 
“associating polymers”, see Chapter 2) to a vesicle solution. For our work in this area, 
we have modified the polysaccharide, chitosan, so that it has hydrophobic alkyl tails 
attached to its backbone. Vesicle gels formed by adding the modified chitosan to 
surfactant vesicles are studied in Chapter 3. In the course of our investigations, we 
found that the structure of vesicles in such gels depends on the concentration of 
polymer relative to that of the vesicles. At high polymer:vesicle ratios, the vesicles 
transform from unilamellar to bilamellar structures. Studies on this transformation of 
vesicle structures are the focus of Chapter 4. Finally, controlled release studies from 
lipid vesicle gels, with a model hydrophilic dye encapsulated in the interior of the 
vesicles, are described in Chapter 5.  
 
1.2.2. Vesicles Loaded into Biopolymer Capsules 
The second type of structure investigated is one where vesicles are embedded 
in capsules formed from biopolymers. Such capsules are created spontaneously when 
a solution of a cationic biopolymer is added dropwise into a solution of an anionic 
biopolymer.15-17 An electrostatic crosslinking occurs at the interface of the drop, 
leading to an interfacial shell (Figure 1.1c) and this shell protects the contents of the 
drop from external stimuli. Our studies on chitosan-gelatin capsules loaded with 
vesicles are described in Chapter 5. Note the container-within-container structure of 
the final material, as depicted in Figure 1.1c. To demonstrate the potential use of 




nanoparticles, and their shells are covalently functionalized with antibodies. 
Controlled release experiments conducted with the vesicle-bearing capsule show that 
the combination of transport resistances from the vesicle bilayer and the capsule 
allow for extended release of encapsulated dye.  
 
1.3. Significance of this Work 
 The studies described in this dissertation are potentially significant from two 
different standpoints: (a) they provide fundamental insight into self-assembly 
processes, such as in biomolecular systems; and (b) the studies provide a foundation 
for new controlled release concepts that could be important for the pharmaceutical, 
cosmetic, food, and agrochemical industries. 
 
First, from a scientific standpoint, the interactions between vesicles and 
amphiphilic polymers are crucial to the behavior of cell membranes and membrane-
bound organelles within a cell. As is well known, every biological membrane consists 
of a combination of lipids as well as amphiphilic polymers (proteins or 
polysaccharides) either spanning the membrane or tethered on one side of the 
membrane. Our studies on a simpler model system of unilamellar vesicles and an 
amphiphilic biopolymer can still provide insight relevant to biomolecular systems. 
For example, our findings in Chapter 4 of a polymer-induced transition from 
unilamellar to bilamellar vesicles may be relevant to the bilamellar structure of 




biomolecular systems, vesicle-polymer interactions are also relevant to the behavior 
of some consumer products, such as fabric softeners, and cosmetic creams. 
 
Secondly, the vesicle gels and vesicle-loaded capsules described in this 
dissertation may be useful for controlled release applications. Compared to vesicles 
alone, the above vesicle-bearing hybrid materials present some benefits. For starters, 
the stability of vesicles is enhanced by embedding them in the soft biopolymer 
matrix. Moreover, the presence of an additional transport barrier enables a slower and 
more extended rate of release for molecules encapsulated in the vesicles. As an added 
benefit, encapsulation within vesicles may also help in maintaining the bioactivity of 
drugs and proteins.4 Vesicles may also be useful as storage depots for hydrophobic 
drugs that cannot be loaded otherwise into gels or capsules. Finally, we will show that 
it is relatively easy to confer targeting capabilities (either by magnetic fields or via 
antibodies) to the capsules, in comparison to the vesicles.   
 
Controlled release applications for vesicle gels could arise either in topical 
drug delivery or as implantable biomaterials. In addition to drugs, such gels could 
also be useful in the cosmetic industry as a way to accomplish topical delivery of 
anti-aging chemicals, for example. Vesicles have also been envisioned as additives in 
foods, for instance to continuously deliver or replenish ingredients that add flavor. 
Since a variety of food products, such as yogurt, jellies, ice cream etc. are in a gel-like 
state, our studies could be relevant in those contexts as well. Applications for the 




example, in the targeting of cancerous tumors. To further explore the use of capsules 
in targeted drug delivery, our group has initiated a collaboration with Dr. Hamid 
Ghandehari’s group at the University of Maryland School of Pharmacy, and these 









In this chapter, we describe some of the basic properties of vesicles, 
associating polymers, and biopolymers. We then briefly describe the techniques that 
we will use in this study, specifically, rheology, neutron scattering, and cryo-TEM. 
The aspects discussed here are of a general nature; literature dealing with more 
specific aspects are discussed in the Introduction sections of succeeding chapters. 
 
2.1. Vesicles and Liposomes 
Vesicles are self-assembled capsules formed in water by lipids, surfactants, or 
block copolymers.1,18 The molecules that form vesicles are amphiphilic, with a 
hydrophilic head (depicted as a blue sphere in Figure 2.1) and hydrophobic tail(s) 
(shown in red). The shell of the vesicle is a bilayer (ca. 2-5 nm in thickness) of these 
amphiphilic molecules, with the hydrophilic heads on both sides of the bilayer and 
thereby exposed to water, while the hydrophobic tails inside the bilayer are shielded 
from water. A vesicle can be considered to form by the folding of amphiphilic 
bilayers, as shown in Figure 2.1. Vesicles with only a single bilayer (or lamella) are 
called unilamellar vesicles (ULVs), while vesicles with several concentric bilayers 





The folding of bilayers into vesicles tends to occur only when the bilayers are 
present at low concentration; at high concentrations, bilayers form a lamellar phase.18 
The tendency for bilayers to fold is driven by a desire to minimize contact of the 
hydrophobes with water at the bilayer ends. Also, the formation of many vesicles 
from a single extended bilayer sheet increases the entropy of the system. 
Nevertheless, it is useful to remember that, at equilibrium, the amphiphiles usually 
exist as a lamellar phase; so, the vesicle state is often of limited stability. In other 
words, given sufficient time, vesicles will get disrupted and form a dilute lamellar 
phase. An important exception to this rule exists in the case of mixed surfactants, 
where vesicles can exist as equilibrium structures.2 
 
Vesicles formed from lipids are referred to as “liposomes”. The term lipid 
usually refers to amphiphiles that have a biological origin and typically, such 
molecules have two hydrophobic (acyl) tails. Lipid bilayers constitute the membranes 
Figure 2.1.  The structure of vesicles formed by the self-assembly of amphiphiles.





found at the boundary of every living cell as well as many intracellular organelles. 
The classification of lipids is done based on their headgroup type –  for example, 
phospholipids have a phosphate moiety in their headgroup. Among the phospholipids, 
the phosphatidylcholines or lecithins are a common variety. Lipids tend to have a 
very low solubility in water because they have two hydrophobic tails. As a result, an 
organic solvent is usually employed in preparing lipid vesicles.  
 
The tendency of lipids to form bilayers or vesicles can be rationalized from 
the geometry of these molecules. Generally speaking, the role of molecular geometry 
in dictating the self-assembly of amphiphiles can be understood by a term called the 





=    (2.1) 
where ahg is the effective area of the amphiphile headgroup and atail is the average 
area of the amphiphilic tail. Amphiphilic molecules having atail ≈ ahg, i.e., CPP = 1, 
tend to assemble into bilayers or vesicles (Figure 2.2). Note that the shape of these 
molecules resembles that of a cylinder. In contrast, molecules with a larger headgroup 
area than tail tend to favor curved structures, specifically micelles. A CPP of ⅓ 
corresponds to spherical micelles while a CPP of ½ corresponds to cylindrical 
(rodlike or wormlike) micelles. 
 
 In addition to lipids (2-tailed amphiphiles), mixtures of single-tailed 
amphiphiles, one cationic and the other anionic, can also form vesicles.2 The 




(Figure 2.2). In this case, each individual surfactant molecule resembles a cone 
because of the electrostatic repulsion from its headgroup. When mixed together, 
however, the cationic and anionic headgroups mutually mitigate their repulsive 
electrostatic effects, leading to a significant reduction in headgroup area. The 
combination of these molecules thus resembles a cylinder, and consequently leads to 
vesicle structures. Interestingly, these surfactant vesicles tend to spontaneously form 
when the two individual surfactants are mixed. Moreover, the vesicles are indefinitely 
stable, which suggests that they may actually be equilibrium structures. 
 
       
 
  
Lipids = Biological Amphiphiles
Two-tailed
+











Figure 2.2.  Role of geometry in bilayer and vesicle formation. Amphiphiles that
have a cylinder-like shape tend to form bilayers. These include lipids (2-tailed





 2.1.1. Vesicle Preparation from Lipids 
As mentioned, lipids are insoluble in water and at equilibrium they tend to 
form a lamellar phase. Therefore, preparation of lipid vesicles calls for the use of an 
organic solvent and some input of energy.1,20 First, the lipid(s) are dissolved in an 
organic solvent such as chloroform. Thereafter, the solvent is removed by evaporation 
to yield a dry lipid film. This film is then hydrated by adding water (or a buffer 
solution) at a temperature above the gel-to-liquid crystal transition of the lipid (Figure 
2.3a). The solution is gently stirred during this process and the result is the formation 
of large multi-lamellar vesicles (MLVs) in solution. To convert the MLVs to 
unilamellar vesicles (ULVs), the lipid solution is either sonicated or extruded through 
a polycarbonate filter of given pore size. Sonication tends to produce small 
unilamellar vesicles (15 – 50 nm in diameter), whereas extrusion is typically used to 
produce unilamellar vesicles with a diameter on the order of 100 nm (Figure 2.3a). 
  
While the above methods yield nanometer-sized vesicles, it is also possible to 
obtain giant unilamellar vesicles (GUVs, or giant vesicles in short) that are several 
microns in diameter.21 Giant vesicles can be seen directly by optical microscopy, 
typically in phase contrast mode. A popular method to form giant vesicles in the size 
range 5 – 200 µm is by electroformation (Figure 2.3b). This involves application of 
an AC voltage across lipid-coated electrodes spanning a water-filled chamber. In this 
process, the giant vesicles break off from the lipid film and their size is controlled by 





Figure 2.3. Preparation of unilamellar lipid vesicles of various sizes: (a) small or














2.2. Associating Polymers 
 The term associating polymer refers to a water-soluble polymer that has an 
amphiphilic character.22 Typically, the polymer backbone is hydrophilic, while 
hydrophobic groups are either present at the ends of the chain (this is called a 
telechelic structure) or the hydrophobes are tethered by chains to the polymer 
backbone (this is referred to as a comb-graft structure). Associating polymers have 
been synthesized by attaching hydrophobes to a range of water-soluble polymers, 
including polyethylene oxide (PEO) and polyacrylamide (PAAm) as well as to 
biopolymers such as cellulose and chitosan.22,23 We will work with chitosan-based 
associating polymers in this study.  
Figure 2.4. Archiecture of a telechelic associating polymer and the structures formed





When added to water, hydrophobes on the polymer associate or self-assemble 
in much the same way as surfactant hydrophobes.22,24 In analogy to the micelles 
formed by surfactants, polymer association is believed to result in “flower micelles” 
(shown in Figure 2.4 for the case of the telechelics), with hydrophobes from many 
chains present at the center of these micelles. Note that at low polymer 
concentrations, there is significant intra-polymer association, while at higher 
concentrations, there is a shift to inter-polymer associations. Thus, at high polymer 
concentrations, the flower micelles function as crosslinks in a transient network, 
thereby enhancing the solution viscosity. For high molecular weights, the polymer 
will both associate as well as entangle with other chains. 
 
2.3. Biopolymers 
Macromolecules of biological origin fall broadly under three classes: 
polypeptides or proteins; polynucleotides; and polysaccharides.25 For the purposes of 
this study, we will focus on polysaccharides. The polysaccharide that is of especial 
interest to us is chitosan and we describe its properties below in more detail. The 
common theme with the chosen biopolymers is their ability to render viscosity to 
water by forming entangled networks or gels.       
 
 2.3.1. Chitosan 
Chitosan is a linear polysaccharide obtained by the deacetylation of chitin.26 




insects and crustaceans. Among biological polymers, chitin is next only to cellulose 
in abundance. However, while chitin is insoluble in water, its deacetylated derivative, 
chitosan, is water-soluble under acidic conditions (pH < 6.5). Under these conditions, 
the amine groups along the chitosan backbone are ionized and chitosan acts as a 
cationic polyelectrolyte. Note that chitosan is strictly a copolymer of mostly 
D-glucosamine (β-(1,4)-2-deoxy-2-amino-D-glucopyranose) sugars and a few of the 
N-acetyl-D-glucosamine (β-(1,4)-2-deoxy-2-acetamido-D-glucopyranose) sugars 
from the parent chitin. The structures of these sugars are shown in Figure 2.5. 
 
Current scientific and technological interest in chitosan is motivated by a 
number of factors.26  First, chitosan is a biocompatible and biodegradable polymer. It 
is one of the few cationic biopolymers, and as a result, it can interact with anionic cell 
membranes. Second, chitosan confers anti-bacterial properties to substrates. As a 
result, chitosan finds application in tissue regeneration, artificial skin constructs, 
wound dressings and sutures, drug delivery, antibacterial coatings, and bioseparation 
Figure 2.5. Structures of the parent sugars in (a) chitin and (b) chitosan. The N-



























membranes.26-30 Third, there is an environmental benefit to using chitosan since the 
parent chitin is usually obtained from food-processing wastes (e.g., crab, shrimp or 
lobster shells). For these reasons, there is ample interest in chitosan and many 
researchers have also attempted to modify the parent polymer to confer it unique 
properties.30-33 One such modification is to attach hydrophobic groups to chitosan, 
and this is discussed below.  
 
 2.3.2. Chitosan Modification 
Chitosan can be modified easily due to its amine groups as well as its primary 
and secondary hydroxyls. Modifications have been done to improve chitosan 
solubility in water, to increase its chelating ability, and to modify its antibacterial 
effect.23,30,34 Our particular interest is in attaching hydrophobic groups to the chitosan 
backbone to alter its association behavior in water. The synthesis of hydrophobically-
modified chitosan (hm-chitosan) is rather straightforward and can be performed under 
mild conditions.23 The procedure involves reacting the chitosan with an n-alkyl 



























groups are converted into NH-R groups, where R is the n-alkyl moiety. The structure 
of hm-chitosan containing C12 hydrophobic tails is shown in Figure 2.6. Note that this 
is a comb-graft type of associating polymer. 
 
A typical procedure for synthesizing hm-chitosan with C12 tails involves the 
following steps.23,34 First, n-dodecyl aldehyde is added to an acidic chitosan solution 
in a water-ethanol mixture, followed by addition of sodium cyanoborohydride. The 
molar ratio of aldehyde to chitosan monomer(s) is fixed at a certain value (e.g. 2.5%). 
The reaction yields the hm-chitosan, which is then precipitated by raising the pH and 
adding ethanol. Next, the precipitate is purified by washing with ethanol followed by 
deionized water. The final hm-chitosan precipitate is re-dissolved in acetic acid 
solution and the concentration is recalibrated. This solution tends to be viscous due to 
associations between the hydrophobes (this is a qualitative indication that the 
synthesis has been successful). The degree of hydrophobic substitution in the final 
product can be compared to the value expected from stoichiometry using 1H NMR.  
 
Hydrophobically modified chitosans with n-alkyl pendant chains can also be 
synthesized by alternate routes, e.g., by reacting with alkyl carboxylic acids35, or 
alkyl acid anhydrides36, or alkyl acid chlorides37. High substitution levels (> 10%) 
have been reported via the acid chloride method. These alternate routes are not 






2.4. Characterization Techniques 
2.4.1. Rheology 
Rheology is formally defined as the study of flow and deformation in 
materials.38 Rheological measurements provide important information on soft 
materials, specifically on the relation between microstructure and macroscopic 
properties. These measurements are typically performed on a rheometer (Figure 2.7) 
under steady or dynamic oscillatory shear. Typical geometries used in rheometers are 
the cone-and-plate, the parallel plate, and the concentric cylinder or Couette. 
 
Figure 2.7.  Photograph of the Rheometer RDA-III strain-controlled rheometer being




In steady shear rheology, the sample is subjected to a constant shear-rate γ  
(e.g. by applying a continuous rotation at a fixed rate on a rotational instrument), and 
the response is measured as a shear-stress σ. The ratio of shear-stress σ to shear-rate 
γ  is the (apparent) viscosity η. A plot of the viscosity vs. shear-rate γ  is called the 
flow curve of the material.  
 
In dynamic or oscillatory rheology, a sinusoidal strain 0 sin( )tγ γ ω= is 
imposed on the sample. Here, γ0 is the strain-amplitude (i.e. the maximum applied 
deformation) and ω is the frequency of the oscillations. The sample response will be 
in the form of a sinusoidal stress 0 sin( )tσ σ ω δ= +  which will be shifted by a phase 
angle δ with respect to the strain waveform. Using trigonometric identities, this stress 
waveform can be decomposed into two components, one in-phase with the strain and 
the other out-of-phase by 90°: 
 0 0sin( ) cos( )G t G tσ γ ω γ ω′ ′′= +   (2.2) 
  where G′  = Elastic or Storage Modulus   
 and G″ = Viscous or Loss Modulus                 
 
 The elastic modulus G′ is the in-phase component and provides information 
about the elastic nature of the material. Since elastic behavior implies the storage of 
deformational energy, this parameter is also called the storage modulus. The viscous 
modulus G″, on the other hand, is the out-of-phase component and characterizes the 




energy, G″ is also called the loss modulus. For these properties to be meaningful, the 
dynamic rheological measurements must be made in the “linear viscoelastic” (LVE) 
regime of the sample. This means that the stress must be linearly proportional to the 
imposed strain (i.e., moduli independent of strain amplitude). In that case, the elastic 
and viscous moduli are only functions of the frequency of oscillations ω, and are true 
material functions. A log-log plot of the moduli vs. frequency, i.e. G′(ω) and G″(ω), 
is called the frequency spectrum or dynamic mechanical spectrum of the material. 
Such a plot represents a signature of the material microstructure.  
 
 The important advantage of dynamic shear is that it allows us to characterize 
microstructures without disrupting them in the process. The net deformation imposed 
on the sample is minimal because the experiments are restricted to small strain 
amplitudes within the LVE regime of the sample. As a result, the linear viscoelastic 
moduli reflect the microstructures present in the sample at rest. This is to be 
contrasted with steady shear, where the material functions are always obtained under 
flow conditions corresponding to relatively drastic deformations. We can therefore 
correlate dynamic rheological parameters to static microstructures, and parameters 
under steady shear to flow-induced changes in microstructure. 
 
2.4.2 Small-Angle Neutron Scattering (SANS) 
Scattering techniques are invaluable probes of the micro- and nanostructure in 
soft materials.39 The basic principle underlying all scattering techniques is that the 




“particles” present. For aqueous systems, small-angle neutron scattering (SANS) is 
the technique of choice because contrast between the “particles” and the solvent can 
be easily achieved by switching H2O with D2O. Also, the incident radiation in SANS 
is composed of neutrons having a wavelength ~ 7 Å, and as a result, SANS is useful 
in probing size scales on the order of a few nm. SANS experiments require a nuclear 
reactor to generate neutrons and we are fortunate to have one of the premier SANS 
facilities in the world close to UMD at NIST in Gaithersburg, MD.  
 
The basic geometry of a SANS experiment is illustrated in Figure 2.8. 
Neutrons emitted from a nuclear reactor are selected at a particular wavelength and 
wavelength spread using a velocity selector, collimated by several lenses, and passed 
through a sample chamber. The neutrons scattered by the sample are collected on a 
2-D detector. This 2-D data is corrected and placed on an absolute scale using 
calibration standards. It is then converted into a plot of scattered intensity I vs. 
scattering or wave vector q by spherical averaging. The wave vector q is related to the 
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Figure 2.8.  Schematic of a SANS experiment. 









Here, λ  is the wavelength of the incident radiation and θ  is the scattering angle. 
Thus, q can be considered an inverse length scale, with high q corresponding to small 
structures, and vice versa.  
 
 The SANS intensity I(q) from a structured fluid containing np particles per 
unit volume can be expressed in the following manner:39 
 p( ) ( ) ( )I q n P q S q= ⋅ ⋅  (2.4) 
where P(q) is called the form factor and S(q) the structure factor. P(q) is the scattering 
that arises from intraparticle interference, which is a function of the particle size and 
shape. S(q) arises from interparticle interactions and thereby reflects the spatial 
arrangement of particles in the sample. When the particles are in dilute solution or are 
non-interacting, the structure factor S(q) → 1 and the SANS intensity I(q) can then be 
modeled purely in terms of the form factor P(q). Different expressions exist for the 
form factor P(q) for various particle geometries. By fitting the appropriate P(q) to the 
SANS data, one can obtain the characteristic sizes of the particles present. 
 
2.4.3 Dynamic Light Scattering (DLS) 
 Static scattering techniques such as SANS provide important information 
about the quiescent structure in complex fluids. Dynamic scattering techniques have a  
complementary role in that they probe structural relaxations and dynamics. In 
particular, dynamic light scattering (DLS) probes the Brownian motion of particles in 
the fluid. This method can give a reliable estimate of particle size under certain 




from the sample is recorded at a certain angle θ. The fluctuations are then correlated 
to yield the intensity autocorrelation function g(2)(q,τ) vs. the correlation time τ:40 
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 (2.6) 
where n is the refractive index of the medium. The relevance of q in DLS is that 
structural relaxations are probed over length scales on the order of q–1.  
 
The measured intensity autocorrelation function g(2)(q, τ) can be converted 
into an electric field autocorrelation function g(1)(q, τ) through the Siegert relation: 
  
2(2) (1)( , ) 1 ( , )g q f g qτ τ= +  (2.7) 
Here, f is an adjustable parameter called the coherence factor that depends on the 
instrument geometry. For a dilute solution of monodisperse spherical particles, the 
electric-field autocorrelation function is a single exponential whose time decay is 
determined by the translational diffusion coefficient of the particle D: 
  ( )(1) 2( , ) expg q Dqτ τ= −  (2.8) 






=  (2.9) 
where kB is the Boltzmann constant, T the absolute temperature and η the viscosity of 




hydrodynamic radius Rh. The hydrodynamic size is the bare particle size along with 
any solvation layer.    
 
2.4.4 Cryo-Transmission Electron Microscopy (Cryo-TEM) 
 While scattering techniques provide indirect information about the 
nanostructure in a sample, an alternate technique that would allow direct visualization 
of the structure in real space would be extremely useful. Transmission electron 
microscopy (TEM) can potentially reveal structural detail with sub-nanometer 
resolution. However, the use of TEM for self-assembled fluids and soft materials is 
problematic. For imaging under TEM, the solvent must be completely removed, and 
the process of solvent removal can alter or destroy fragile structures such as micelles 
and vesicles. Also, to achieve contrast, structures usually have to be stained with 
heavy metal salts – again, the staining process might degrade the structures present.  
 
 The above deficiencies of conventional TEM techniques have led researchers 
to develop an alternative that is particularly suited for aqueous nanostructured fluids. 
This technique is called cryo-TEM, and it involves the rapid freezing of the aqueous 
sample such that the water is vitrified instead of forming ice crystals. In the process, 
the structural details are preserved, and the sample can be imaged under conventional 
TEM at low electron doses. Sample preparation for cryo-TEM is conducted using a 
controlled environment vitrification system (CEVS), illustrated in Figure 2.9. In the 
CEVS, the sample is equilibrated at conditions of controlled temperature and 




carbon film supported on a TEM grid. A filter paper is then used to blot the drop, so 
as to create a thin film of the sample spanning the grid holes. The grid is then plunged 
into the cryogen, liquid ethane, thereby rapidly vitrifying the sample. Subsequently, 
the grid has to be transferred to the electron microscope in a dedicated cold stage. 
Typically, the grid is maintained at –170°C at all times, to ensure that there is no 
formation of ice crystals nor condensation of atmospheric water.  
Figure 2.9.  Photograph of the controlled environment vitrification system (CEVS)
used for sample preparation in cryo-TEM. The schematics on the left show the




As with any other technique, care has to be taken in interpreting cryo-TEM 
data. One frequent source of artifacts is that the sample blotting process (used to 
spread a thin film) involves a substantial amount of shear. This shear may distort the 
structures present, and one has to take this into account while interpreting images. 
Despite these artifactual concerns, cryo-TEM has now developed into a powerful tool 
for directly probing the structures of various complex fluids. A variety of self-
assembled structures including micelles, vesicles and liquid crystalline phases have 
been successfully imaged by cryo-TEM. Also, the use of cryo-TEM in biology has 







Vesicle Gel Networks Anchored by 
an Associating Biopolymer 
 
The results in this chapter have been published in the following journal article: 
Jae-Ho Lee, John P. Gustin, Tianhong Chen, Gregory F. Payne and Srinivasa R. 
Raghavan, “Vesicle-biopolymer gels: Networks of surfactant vesicles connected by 
associating biopolymers.” Langmuir 21, 26-33 (2005). 
 
3.1. Introduction  
In this chapter, we discuss our first study, which is focused on mixtures of 
vesicles with an associating biopolymer. The biopolymer is the polysaccharide, 
chitosan, to which we attach n-dodecyl tails to convert it into an associating 
biopolymer. We then show that the addition of this polymer to vesicles results in the 
formation of “vesicle gels”. These gels are studied by a combination of rheological 
and scattering techniques, and their likely structure is elucidated. As discussed in 
Chapter 1, our motivation for this work is that the gelation of vesicles can be 
considered a means of entrapping and stabilizing them within a soft matrix. Vesicle 





3.1.1. Associating Polymer–Vesicle Mixtures: Previous Work  
An associating polymer is one with a hydrophilic backbone and pendant 
hydrophobic groups, as discussed in Chapter 2. While a number of previous studies 
have investigated mixtures of associating polymers with surfactant micelles, only a 
few studies have investigated these polymers in conjunction with vesicles. Because 
associating polymers bear hydrophobes, their interactions with vesicles will be 
primarily dictated by hydrophobic interactions. If the hydrophobic tails are long 
enough, they can become embedded in vesicle bilayers and the polymer chain can 
thereby remain bound to the vesicles through its hydrophobes. The situation is more 
complicated when the associating polymer itself bears charge (i.e., when it is a 
polyelectrolyte) and the vesicles also bear charge. In the latter case, the net interaction 
forces will be mediated by a combination of hydrophobic interactions and 
electrostatic interactions.42  
 
Several scenarios can arise as a result of interactions between associating 
polymers and vesicles. In the simplest scenario, the polymer chains will adsorb on the 
vesicles through their hydrophobes and act as a stabilizer, i.e., they will impart 
repulsive interactions to the vesicles.43 More complicated outcomes can also arise. It 
is important to note that vesicles are self-assembled entities, and they can thus 
undergo changes in morphology or shape due to binding of polymer hydrophobes. 
For example, associating polymers have been known to transform spherical vesicles 
into faceted (polygon) structures.43,44 Of particular relevance to the present study is 




are formed only when there are sufficient numbers of both polymers and vesicles to 
create a three-dimensional network. A similar network can also be created with cells, 
rather than vesicles, with associating polymers bound to cell membranes.11 
 
So far, studies on vesicle gels have largely been carried out with synthetic 
associative polymers, obtained typically by attaching hydrophobic moieties to water-
soluble synthetic polymers such as polyethylene oxide (PEO) or polyacrylamide 
(PAAm). In this study, we are interested in creating vesicle gels with an associating 
biopolymer, viz., a hydrophobically-modified chitosan (hm-chitosan). Our use of 
chitosan is a step towards ensuring the biocompatibility of candidate systems for drug 
delivery.27 The synthesis of an hm-chitosan with n-dodecyl tails randomly tethered 
along its backbone has been described in Section 2.3.2. Earlier investigations with 
hm-chitosan have focused on its associating properties in water, which has been 
studied using scattering and rheological techniques. Mixtures of hm-chitosan with 
surfactant micelles have also been studied, but there have not been any previous 
studies of hm-chitosans with vesicles. 
 
3.2. Materials and Methods  
Chitosan. Chitosan of medium molecular weight (190–310K) and Brookfield 
viscosity of 286 cps was obtained from Aldrich. The degree of deacetylation was 
reported to be ca. 80% by the manufacturer and this has been verified by NMR. 




acetic acid to control the pH in chitosan solutions. Chitosan acts as a cationic 
polyelectrolyte under these conditions. 
 
Hydrophobically-Modified Chitosan (hm-Chitosan). hm-chitosan with 
n-dodecyl tails was synthesized as described in Section 2.3.2 and its structure is 
shown in Figure 2.7. The molar ratio of aldehyde to that of the chitosan monomer(s) 
was fixed at 2.5% in this study. The final hm-chitosan precipitate was re-dissolved in 
1% acetic acid. As expected, this solution was highly viscous. NMR studies on the 
hm-chitosan indicated that the degree of hydrophobic substitution was close to that 
expected from reaction stoichiometry. Similar substitution levels have been reported 
by others.45,46  
 
Vesicles. Surfactant vesicles were prepared by mixing the cationic surfactant, 
cetyl trimethylammonium tosylate (CTAT), and the anionic surfactant, sodium 
dodecyl benzene sulfonate (SDBS). The surfactants were purchased from Aldrich and 
all solutions were made using distilled-deionized water. The phase diagram for 
CTAT/SDBS mixtures has been reported previously47 and the water-rich corner of 
this diagram is redrawn in Figure 3.1. Unilamellar vesicles are present in the two 
lobes extending from the water corner. The left-hand lobe corresponds to CTAT-rich 
or cationic vesicles, and our attention was primarily focused on these compositions. 
The weight ratio of 70/30 CTAT/SDBS in the middle of this lobe was the 





Sample Preparation and Phase Characterization. Surfactant and polymer 
mixtures of desired composition were prepared by mixing the corresponding stock 
solutions. Samples were mildly heated at 50°C for two hours, followed by 
centrifugation to remove bubbles. The sol-gel phase boundary was evaluated visually 
by tube inversion (details under Results). For SANS experiments, the samples were 
prepared in D2O, obtained from Cambridge Isotopes. The hm-chitosan was vacuum 
dried before solubilization in D2O.  
 
Dynamic Light Scattering (DLS). Vesicle solutions were studied at 25°C 
using a Photocor-FC light scattering instrument with a 5 mW laser light source at 633 
nm. The scattering angle was 90° and a logarithmic correlator was used to correlate 
the intensity. The data yielded the hydrodynamic size of vesicles, as described in 

































Figure 3.1.  Water-rich corner of the CTAT/SDBS/Water ternary phase diagram,
redrawn from Ref. 41. All concentrations are expressed in weight%. The focus of this
study is on the cationic vesicle phase, with the composition of choice being a 70/30




Rheological Studies. Steady and dynamic rheological experiments were 
performed on a Rheometrics RDA III strain-controlled rheometer. Cone-and-plate 
geometries (25 mm dia., 0.01 rad cone angle, or 50 mm dia., 0.04 rad cone angle) 
were used. Dynamic frequency spectra were obtained in the linear viscoelastic regime 
of the samples, as determined by dynamic strain sweep experiments.   
 
Small-Angle Neutron Scattering (SANS). SANS measurements were made 
on the NG-3 (30 m) and NG-1 (8 m) beamlines at the National Institute of Standards 
and Technology (NIST) in Gaithersburg, MD. Samples were studied at 25°C in 2 mm 
quartz cells. The scattering spectra were corrected and placed on an absolute scale 
using calibration standards provided by NIST. The final reduced data is plotted as the 
radially-averaged, absolute intensity I versus the wave vector q. 
 
3.2.1. SANS Modeling of Vesicles  
We will use SANS as a tool to characterize the sizes of vesicles. The analysis 
requires fitting the SANS data to a suitable model, which is described below. As 
discussed in Chapter 2, for a dilute solution of non-interacting vesicles, the structure 
factor S(q) → 1, and the SANS intensity I(q) is dictated solely by the form factor 
P(q). The form factor P(q) for unilamellar vesicles of radius R and bilayer thickness 
t is given by the following expression:39,48 
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where (∆ρ) is the difference in scattering length density between the vesicle bilayer 
and the solvent. (∆ρ)2 is thus a measure of the scattering contrast. J1(x) is the first-
order Bessel function, given by:  
 1 2
sin cos( ) x x xJ x
x
−
=  (3.2) 
For thin bilayers (t << R), or equivalently for large vesicles, P(q) reduces to the 
following expression:     
 ( ) ( ) ( )
2
2 2 2
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tP q R qR
q
ρ π= ∆ ⋅ ⋅  (3.3) 
Eq 3.3 indicates that for large, non-interacting vesicles, I(q) should show a q−2 decay 
in the low q range. If, the vesicles are polydisperse, the form factor has to be averaged 
over the vesicle distribution in the following manner: 39,48  
 ( )( ) ( ) ,P q f R P q R dR= ⋅∫  (3.4) 
where P(q, R) is the form factor for a vesicle of radius R (eq 1). The polydispersity in 
vesicle radius f(R) can be accounted for by a Schultz distribution:  
 
( ) ( )
1
0 0
1( ) exp 1
1
p pp R Rf R p
R p R
+
⎛ ⎞ ⎛ ⎞+
= − +⎜ ⎟ ⎜ ⎟Γ +⎝ ⎠ ⎝ ⎠
 (3.5) 
In the above expression, R0 is the average vesicle radius and p the polydispersity 














3.3. Results  
We performed our initial studies with CTAT/SDBS solutions at a total 
surfactant concentration of 1 wt.%, indicated in Figure 3.1 by a dashed horizontal 
line. Samples with various weight ratios of CTAT to SDBS along this line were 
prepared. When the hm-chitosan was added to samples rich in the anionic surfactant, 
SDBS, a precipitation occurred, the reasons for which will be clarified in Chapter 5. 
Our focus here will be restricted to compositions rich in the cationic surfactant, 
CTAT, i.e., those compositions to the left of the equimolar line in Figure 3.1. Within 
this composition range, samples in the CTAT-rich corner (CTAT/SDBS weight ratios 
from 100/0 to about 91/9) consist of rodlike or wormlike micelles. For slightly higher 
SDBS content (CTAT/SDBS ratios ca. 70/30), unilamellar vesicles spontaneously 
form at equilibrium. Note that these micelles and vesicles both bear a positive charge 
due to an excess of CTAT. The weight ratio of 70/30 CTAT/SDBS (ca. 2:1 molar 
ratio) falls in the middle of the vesicle lobe and we fixed this composition for the 
majority of our vesicle studies.  
 
The addition of hm-chitosan has a visible and dramatic effect on CTAT/SDBS 
vesicles. Consider a 1% mixture of CTAT/SDBS at a 70/30 weight ratio. This sample 
is located in the vesicle lobe and is a nonviscous, bluish solution, reflecting the 
presence of unilamellar vesicles (Figure 3.2a). DLS measurements reveal that the 
vesicle diameter is approximately 120 nm in this sample. When a solution of 0.55% 
hm-chitosan is added, the sample is instantaneously transformed into an elastic gel 




nonviscous vesicle solution with a small amount of hm-chitosan results in a gel. 
Interestingly, as seen in Figure 3a, the gel has the same bluish color as does the 
vesicle solution.   
 
3.3.1. Phase Behavior and Rheology  
 We studied numerous vesicle-polymer mixtures to map out the rheological 
“phase diagram” shown in Figure 3.2b. This is a plot of hm-chitosan concentration 
Figure 3.2. (a) Photograph of a CTAT/SDBS vesicle solution before and after
addition of hm-chitosan. The polymer transforms the vesicle solution into an elastic
gel that is able to hold its own weight in the inverted vial. (b) Phase map of the
hm-chitosan/vesicle system showing the sol-gel boundary obtained by tube inversion
experiments. This boundary separates samples that are viscous sols from those that
are strong elastic gels. An approximate boundary estimated from rheological data,
corresponding to the onset of a weak gel (non-zero equilibrium modulus) is also
indicated. Dynamic rheological data for the samples marked by unfilled circles are


























From tube inversion: onset 
of “strong” gel (G0 > 4 Pa)
From rheology: onset of gel































against total surfactant concentration, with the surfactant ratio fixed at 70/30 
CTAT/SDBS. The path of increasing surfactant at this ratio is indicated on the phase 
diagram (Figure 3.1) by a dashed line. Figure 3.2b shows a sol-gel phase boundary 
demarcated by tube inversion experiments. Tube inversion is frequently employed in 
studying gels, and is basically a measure of sample yield stress.49 Thus, a gel-like 
sample with sufficient yield stress will be able to hold its own weight in an inverted 
vial (Figure 3.2a), whereas a viscous sol with a non-existent or low yield stress will 
drop down. We employed the same amount of sample in identical vials for the tube 
inversion experiments and observed each sample for several minutes after inversion. 
As will be shown by rheological measurements, the boundary from tube inversion 
corresponds to the onset of a “strong” gel, with a modulus around 4 Pa. The boundary 
represents an inverse relationship between the polymer and the vesicle 
concentrations. This implies that the onset of a gel requires both a critical vesicle as 
well as a critical polymer concentration.   
 
The onset of gelation was then studied using dynamic rheology. Figure 3.3 
compares the frequency response of four samples with identical hm-chitosan 
concentrations of 0.55%. The first sample contains no surfactant and the remaining 
three are vesicle samples (70/30 CTAT/SDBS) with varying surfactant 
concentrations. The data shows the elastic modulus G′ and the viscous modulus G″ as 
functions of the angular frequency ω. The 0.55% polymer solution is a Newtonian 
fluid with a viscosity around 35 mPa.s. Its dynamic rheological response reflects its 





exceeding G′ over the entire range of frequencies. At 0.01% surfactant (Figure 3.3b), 
the rheology is similar to that of the hm-chitosan alone, with a slight increase in the 
values of both moduli. Increasing the surfactant to 0.35% causes no dramatic changes 
in the rheology, with G″ still exceeding G′ over the frequency range (Figure 3.3c). 
However, the slopes of G″ and G′ on the frequency spectrum become nearly equal, 
reminiscent of the gel point rheology of a crosslinking polymer.50 A further increase 
in surfactant to 0.5% induces a qualitatively different rheological response (Figure 
3.3d). In this case, at low frequencies, G′ reaches a plateau (G′ = G0, the gel modulus, 
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Figure 3.3. Dynamic rheology of vesicle-polymer mixtures as a function of surfactant
content. The hm-chitosan is maintained at 0.55% and the CTAT/SDBS ratio is held
fixed at 70/30 (within the vesicle region). Data are plotted for (a) polymer with no
surfactant; (b) with 0.01% surfactant; (c) with 0.35% surfactant; and (d) with 0.5%
surfactant. Samples (a) and (b) are viscous sols, (c) is close to the sol-gel transition,





as ω → 0) and its value exceeds that of G″. This indicates elastic behavior, and the 
lack of frequency dependence implies that the sample does not relax, i.e., it has an 
infinite relaxation time. Thus the 0.5% sample satisfies the strict rheological 
definition of a gel.38  
 
 Based on visual inspection, the 0.5% surfactant sample (Figure 3.3d) appears 
to be gel-like; however, it did not pass the tube inversion test. This suggests that the 
tube inversion boundary in Figure 3.2b is a conservative estimate and corresponds to 
a higher value of the gel modulus G0 than at the onset of rheological gelation. The 
dynamic rheology of a “strong gel” that satisfies the tube inversion test is shown in 
Figure 3.4a. This sample contains 1.4% surfactant and 0.5% hm-chitosan. In this case, 
the elastic modulus G′ exceeds the viscous modulus G″ over the entire range of 
frequencies, and both moduli are frequency-independent. Note also that the “strong 
Shear rate (s-1)
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Figure 3.4. Comparison of the native and hydrophobically-modified polymers with
regard to their influence on surfactant vesicles. Rheological data under (a) dynamic
shear, and (b) steady shear are shown for two samples, each with the same vesicle
concentration, i.e., 1.4% CTAT/SDBS at a ratio of 70/30. One sample contains 0.5%




gel” in Figure 3.4a has a gel modulus G0 of about 100 Pa, which is much higher than 
the G0 of ca. 0.7 Pa for the weak gel in Figure 3.3d. Based on our rheological data, 
the tube inversion boundary in Figure 3.2b corresponds to a gel modulus of about 4 
Pa. We can also draw an approximate boundary corresponding to the onset of gelation 
from the dynamic rheological data, and this is shown by the dashed curve in Figure 
3.2b. The two boundaries have roughly the same shape.  
 
  Figure 3.4 also compares the hm-chitosan and the unmodified chitosan in 
terms of their effect on surfactant vesicles. The dynamic rheology of two samples 
containing 1.4% surfactant vesicles and 0.5% polymer are contrasted in Figure 3.4a. 
As discussed above, the hydrophobically modified polymer gives rise to a strong gel 
that holds its weight under tube inversion. In contrast, the unmodified chitosan merely 
transforms the bluish vesicle solution into a cloudy and slightly viscous fluid. The 
cloudiness reflects the onset of phase separation and suggests that the vesicles may be 
disrupted and/or aggregated into larger structures by the chitosan. The dynamic 
rheology of the chitosan sample (Figure 3.4a) confirms its viscous behavior, with 
both moduli being dependent on frequency and the viscous modulus G″ exceeding the 
elastic modulus G′.  
 
The contrast between the unmodified and hydrophobically-modified chitosan 
samples is further reinforced by their response under steady-shear (Figure 3.4b), 
where the viscosity is plotted as a function of shear rate for each case. The 
chitosan/vesicle mixture is a Newtonian fluid over the range of shear rates, and its 




shear-thins and its viscosities are ca. four orders of magnitude higher. This response 
shows the gel-like character of the sample, with the viscosity being infinite in the 
limit of zero shear rate. Figures 3.4a and 3.4b show that a gel is formed only when the 
chitosan is hydrophobically-modified.  
 
 We have studied the rheology of vesicle-polymer gels as a function of 
polymer and vesicle concentrations. In Figure 3.5a, the hm-chitosan is maintained at 
0.55% and the gel modulus G0 is plotted against vesicle concentration (i.e., total 
surfactant concentration at a CTAT/SDBS ratio of 70/30). Note that we tabulate G0 
only for gels, i.e., for samples that show a low-frequency plateau in the elastic 
modulus G′. We find that G0 sharply increases with vesicle concentration, the 
approximate relationship being 30 ves~G c  (the best-fit line through the log-log plot in 


























































Figure 3.5. Gel modulus G0 of vesicle gels formed by adding hm-chitosan to
CTAT/SDBS mixtures: (a) as a function of vesicle concentration at a constant
hm-chitosan concentration of 0.55%; (b) as a function of polymer concentration at a




concentration was maintained at 1% and the hm-chitosan concentration was varied. In 
this case, the gel modulus G0 increases linearly with polymer content (G0 ~ cpoly), as 
shown by the plot in Figure 3.5b (the best fit slope is 1.25). The significance of these 
relationships will be discussed in the next section.  
 
3.3.2. SANS  
To probe the microstructure in our samples, we carried out SANS 
measurements. Samples for SANS were prepared in D2O to achieve the needed 
contrast between the microstructure and the solvent. The D2O samples were visually 
and rheologically identical to their counterparts made with H2O. Figure 3.6 shows 
SANS spectra for the control vesicles (no polymer) and for a vesicle gel made by 
adding hm-chitosan to those vesicles. In both cases, the scattered intensity I(q) shows 
Figure 3.6. SANS data for a vesicle solution and the corresponding gel obtained by
adding 0.55% hm-chitosan to this solution. The vesicle solution consists of 1%
CTAT/SDBS at a ratio of 70/30. Both samples show the –2 slope characteristic of
bilayer scattering. 


































a q−2 decay at moderate q, which is characteristic of bilayer scattering (eq 3.3). Data 
fits using the model for polydisperse unilamellar vesicles (eq 3.4 – 3.6) are shown in 
Figure 3.6 as solid lines. From the model fit, the vesicles in the control sample (1% 
CTAT/SDBS at a 70/30 ratio) are seen to have an average radius R0 of ca. 62 nm, 
with the polydispersity in the radius σR, being ca. 26%. The bilayer thickness is 
2.5 nm and this can be confirmed in a model-independent fashion using a modified 
Guinier plot of ln(Iq2) vs. q2 as well.48 The parameters determined here are consistent 
with previous reports on CTAT/SDBS vesicles.51  
 
Turning now to the vesicle gel, we find that its SANS spectrum shows both 
the q–2 dependence at moderate q and the incipience of a form factor minimum at low 
q. This suggests that the unilamellar vesicles present in the gel are smaller than the 
control case. From the model fit, we obtain an average vesicle radius R0 of 18 nm, 
with the polydispersity in the radius σR being about 26%. The bilayer thickness is 
2.5 nm as before. Note that we obtain a reasonable fit for the vesicle gel without 
including a structure factor S(q) in the model, implying that electrostatic or excluded 
volume effects are not significant for the composition studied. Also, the scattering 
from vesicles dominates over that from the hm-chitosan in the sample, which is why 
we can model the data based on vesicles alone. To summarize, the key finding from 
Figure 3.6 is that the surfactant vesicles appear to remain intact within the gel. In 
addition, the vesicles in the gel appear to be significantly smaller (18 nm radius) than 





3.4. Discussion  
  
The addition of hm-chitosan to surfactant vesicles results in a “permanent” 
gel, i.e., one that does not relax even after infinite time (Figures 3.3d, 3.4). The gel is 
formed only when the polymer has hydrophobes (Figure 3.4) and we know from 
SANS that the vesicles remain intact in the gel (Figure 3.6). Based on these findings, 
the likely structure of the gel is that of a network of vesicles bridged by hm-chitosan 
chains, as depicted in Figure 3.7. Here, a fraction of the polymer hydrophobes 
(stickers) are shown to be embedded in vesicle bilayers, so that each polymer chain is 
connected to two or more vesicles. The vesicles thus serve as multifunctional 
Figure 3.7. Proposed structure of network formed upon addition of hm-chitosan to
vesicles. Polymer hydrophobes are shown to be embedded in vesicle bilayers, thus
building a connected network of vesicles. Each vesicle acts as a multifunctional




crosslinks in a polymer gel network. The permanence of the vesicle gel is probably 
due to the slow rate of monomer exchange between vesicle bilayers.18 That is, in 
contrast to micelles, vesicles do not break and re-form frequently, so that a 
hydrophobe can remain trapped in a given vesicle for a considerable period of time. 
Our interpretation of the vesicle gel structure coincides with that of other researchers 
on similar vesicle-polymer mixtures.10-14    
 
 To facilitate further analysis, we estimate some relevant length scales in a 
typical vesicle gel. Consider a 1 wt.% CTAT/SDBS 70/30 mixture with 0.55 wt.% 
hm-chitosan. Based on the vesicle size (from SANS, Figure 3.6) and concentration, 
we estimate the distance between adjacent vesicle surfaces to be ca. 80 nm. Taking 
the hm-chitosan next, the contour length of a chain of molecular weight 200,000 is 
ca. 625 nm, assuming a repeat unit size of 0.5 nm.46 Each chain has about 25 
hydrophobes, located about 25 nm apart along the chain. The reported persistence 
length lp of hm-chitosan is 7.5 nm at high ionic strength,46 which implies a radius of 
gyration Rg in dilute solution of 28 nm. The lp should be higher in our samples (i.e., 
the chains should be more rod-like) because our ionic strength is low; thus, our Rg 
should also be higher. Additionally, for the same molecular weight, the hm-chitosan 
concentration at overlap c* is reported to be about 0.1 wt.%.45,46 Beyond c*, polymer 
coils overlap and begin to form “flower micelles”. For c > 10 c* or so, a viscoelastic 
network of flower micelles is expected to form, causing a sharp increase in the 




35 mPa.s, Figure 3.3a) – so at this concentration, the polymer coils are overlapped, 
but only weakly entangled.   
  
 Combining the above calculations, we note that in a typical vesicle gel the 
distance between two vesicles is much less than the contour length of an hm-chitosan 
chain and on the same order as its radius of gyration Rg. In such cases, the formation 
of polymer bridges between vesicles is indeed a plausible outcome. Theories suggest 
that polymer chains gain conformational entropy when vesicles are at the right 
distance for bridging, effectively leading to a bridging “attraction”.52-54 In this 
context, we assume that hydrophobes on the polymer will tend to anchor within the 
vesicle bilayer, and indeed this is expected to occur provided the hydrophobes are 
sufficiently long.42 Moreover, in such cases, the free energy of hydrophobic 
interactions can overcome electrostatic repulsions between the polymer and the 
vesicles.42 This explains why we observe gelation in like-charged (cationic) polymer 
and vesicle mixtures.  
 
 Our data for the onset of gelation and for the sol-gel boundary are broadly 
consistent with the above physical picture. Gelation occurs only above ca. 0.05% 
polymer (the asymptotic y-axis value in Figure 3.2b), which is close to the overlap 
concentration c*. Below this concentration, the polymer is able to link a few vesicles, 
but there are too few chains to form a sample-spanning network. Similarly, gelation 
occurs only when the vesicle concentration exceeds ca. 0.2 wt.% (the asymptotic x-




apart that the entropic penalty in stretching polymer chains to bridge vesicles would 
be excessive. Our sol-gel boundary is comparable to data reported by Porte et al.54 for 
a similar class of networks, consisting of microemulsion droplets bridged by 
telechelic associating polymers. The “percolation line” determined by these authors 
has the same shape and occurs over approximately the same volume fraction range as 
our sol-gel line.54 Thus, our sol-gel boundary is suggestive of a percolation threshold, 
corresponding to the onset of an infinite cluster of bridged vesicles. 
 
 We also observe that the vesicle size seems to be modified by the addition of 
hm-chitosan. Specifically, in the case of the 1% CTAT/SDBS sample (Figure 3.6), 
the vesicles become much smaller upon adding the hm-chitosan (the radius decreases 
from 62 nm to 18 nm). This, in turn, implies a sharp increase in the vesicle number 
density, and thereby an increase in the net surface area of the vesicles. The average 
distance between vesicles is then reduced from ca. 150 nm in the control sample to 80 
nm in the presence of polymer. We interpret these changes as a response of the 
system to promote vesicle-polymer interactions. Because the insertion of 
hydrophobes into vesicle bilayers is energetically favorable, the vesicles rearrange so 
as to present more surface area to the polymer and thereby accommodate more 
hydrophobes. At the same time, the reduction in intervesicle distance enables the 
polymer to bridge adjacent vesicles. The binding of polymer to the outer leaflet of the 
vesicle may also stiffen the bilayer and thereby stabilize the higher extent of 





 Next, we briefly discuss the observed trends in vesicle gel rheology. The gel 
modulus G0 is a measure of the density of elastically-active crosslinks in the gel. We 
have found that G0 increases linearly with polymer concentration cpoly (Figure 3.5b), a 
trend observed also by Meier et al.11 for their vesicle gels formed with telechelic 
polymers. A possible interpretation is that each polymer chain binds to a certain 
number of vesicles, so G0 should be proportional to cpoly times this number. Note that 
a very different scaling is expected for an entangled network of polymers or wormlike 
micelles, where the plateau modulus 2.25p poly~G c .
38 Thus, the observed linear 
dependence of the modulus reflects the distinctive nature of the networks studied 
here, where it is the vesicles that serve as junction points for the polymer chains.  
 
We have also found that the gel modulus G0 increases with the cube of the 
vesicle concentration, i.e., 30 ves~G c  (Figure 3.5a). The same cubic relationship has 
been obtained for the moduli of densely packed unilamellar57 or multilamellar58 
vesicles. In those cases, the vesicle volume fraction was much higher and the 
modulus arose from the contact of individual vesicles. Here, it is the polymer chains 
that build the network, with the vesicles acting merely as junction points in a polymer 
network. The shear modulus of a semidilute polymer network is G0 ≈  kBT/ξ3, where 
kBT is the thermal energy and the correlation length ξ is associated with the network 
mesh size.38 If this relation is assumed to apply for our vesicle gels, it implies that the 
mesh size varies inversely with the concentration of vesicles, i.e., ξ  ~ 1/cves. While 
this result is interesting, further theoretical work is necessary to explore its meaning 




 Finally, we should add that vesicle gels can be created from all kinds of 
vesicles. We have prepared lipid vesicles (liposomes) using phosphatidylcholines, 
and as expected, upon adding hm-chitosan the liposome solution turns into a gel. 
Controlled release studies from these “liposome gels” will be described in Chapter 5. 
In other experimental work (data not shown) we have investigated the effect of 
varying the hm-chitosan molecular weight and the density of grafted hydrophobes. 
Vesicle gels are formed in all cases, and their gel modulus appears to increase with 
both polymer molecular weight and hydrophobe density. The vesicle gels are also 
found to retain their gel-like character over a wide range of temperatures. 
 
3.5. Conclusions  
In this Chapter, we have described studies on mixtures of an associating 
biopolymer, hm-chitosan, with vesicles. The addition of hm-chitosan to vesicle 
solutions transforms them into elastic gels that can hold their own weight upon tube 
inversion. These gels retain the bluish color that arises due to light scattering from 
vesicles, and SANS spectra confirm the existence of vesicles within the gel. The 
rheological response of the gels is typical of elastic solids, with frequency-
independent dynamic shear moduli. The gel modulus increases linearly with polymer 
concentration and with the cube of the vesicle concentration. It is likely that the 
microstructure of these gels comprises a network of vesicles connected by hm-
chitosan chains, with the hydrophobes on the polymer embedded in vesicle bilayers. 
Upon adding the polymer, the vesicle appear to re-organize into smaller entities so as 





Vesicle Morphology Changes Induced 
by an Associating Biopolymer 
 
A condensed version of this chapter will be published in the following journal article: 
Jae-Ho Lee, Vivek Agarwal, Arijit Bose, Gregory F. Payne and Srinivasa R. 
Raghavan, “Transition from unilamellar to bilamellar vesicles induced by an 
amphiphilic biopolymer.” Physical Review Letters  (2006) (in print). 
 
4.1. Introduction  
In this chapter, we report further studies with the vesicle gels from Chapter 3.   
Samples over a range of vesicle and hm-chitosan concentrations are characterized in 
detail by SANS and by the technique of cryo-TEM. The results from these studies 
further reinforce the conclusions drawn from Chapter 3, while also indicating 
additional intricacies. In particular, SANS and cryo-TEM both reveal an interesting 
transition in the morphology of vesicles from the original unilamellar structures to 
bilamellar structures with increasing hm-chitosan to vesicle ratio. The SANS patterns 
for co-existing vesicles of different lamellarity are particularly unusual, with multiple 
peaks occurring at high values of the wave vector. We show how to analyze this 
SANS data by combining existing analytical models for unilamellar vesicles and 




4.1.1. SANS Modeling of Lamellar Phases : Previous Work 
A lamellar phase is a periodic stack of bilayers, as shown in Figure 4.1a. The 
scattering of radiation from a lamellar phase will be dominated by structure factor 
effects, which will result in interference peaks in the intensity I(q), as shown 
schematically in Figure 4.1b. The relative positions of the peaks represent the 
signature of a lamellar phase – if the first-order peak is located at a wave vector q0, 
the second-order peak will be centered around 2q0, the third-order peak at 3q0 and so 
on. The wave vector q0 corresponds to the spacing between the bilayers in the 
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Figure 4.1. (a) Schematic of a lamellar phase, which consists of a periodic stack of
bilayers. The bilayers are shown to be fluctuating (undulating) due to thermal motions.
The periodicity of the bilayers is represented by the d-spacing, which is indicated in the
figure. (b) Typical scattering pattern expected from a lamellar phase. The peak positions
occur at integral multiples of the primary peak location q0. The d-spacing can be obtained




In addition to the bilayer spacing, it is possible to obtain additional 
information about the bilayers from their scattering pattern. Consider a periodic stack 
of N correlated bilayers (i.e., with well-defined bilayer spacing). As the number N 
increases, the main lamellar peak is expected to grow higher. However, a second 
factor to be considered is that the bilayers will also be constantly undergoing thermal 
fluctuations (as depicted in Figure 4.1a). These fluctuations will weaken the inter-
bilayer correlations, which will be reflected in the scattering data as a widening of the 
main lamellar peak and a loss of higher-order peaks. The extent of thermal 
fluctuations will depend on the rigidity of the bilayers – rigid bilayers will fluctuate 
weakly, whereas floppy bilayers will show large-amplitude fluctuations. This implies 
that the scattering data from rigid bilayers should show multiple, sharp peaks, while 
that from floppy bilayers would show a single diffuse peak.       
 
The above qualitative arguments have been placed on a quantitative footing 
by Nallet et al.59 Their model for bilayer scattering provides analytical expressions for 
the form factor PB(q) and structure factor SB(q) of a stack of N bilayers. The total 
scattered intensity is given by: 
 B B2( ) ( ) ( )
CI q P q S q
q
= ⋅ ⋅  (4.2) 
The 1/q2 term is the so-called Lorentz factor, and the constant C is related to the area 
of the basal lamellar plane. The bilayer form factor PB(q) is given by the equation 
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The structure factor SB(q) for bilayers is defined in different ways in the Nallet model 
depending on whether the number of correlated bilayer stacks N is small or large. For 
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where qz = q – q0. Here d is the d-spacing of the bilayers, which can be independently 
calculated from the peak positions (eq 4.1). The parameter η is called the Caillé 












Here kB is the Boltzmann constant, T the absolute temperature, K the curvature 
modulus (related to the bilayer bending modulus), and B  the compression modulus. 
Thus, the Caillé parameter η is inversely related to a product of two elastic constants 
characterizing the stiffness or rigidity of the bilayer. The limits for η are from 0 to 
1.3, with η  = 0 implying very rigid bilayers, and correspondingly, there will be 
multiple sharp peaks in the scattering pattern. On the other hand, higher values of η 
correspond to flexible bilayers and in this case, the higher-order peaks may be absent. 
Note that if the interactions between bilayers are dominated by entropy (i.e., other 
interactions such as electrostatics are negligible), the bilayers will be quite flexible, 
and η will follow the simpler geometrical relationship below, which depends only on 












4.1.2. Polymer Effects on Lamellar Phases : Previous Work 
A few authors have studied mixtures of associating polymers (polysoaps) and 
surfactant lamellar phases. Prud’homme et al. found that hydrophobically-modified 
polyacrylic acid (hm-PAA) was largely miscible with a nonionic lamellar phase, 
whereas the parent PAA polymer was largely immiscible.61 The authors studied the 
hm-PAA samples using SANS and analyzed their data by the Nallet model above. 
They found that the bilayer rigidity increased systematically with increasing polymer 
concentration. Ligoure and co-workers have also used the Nallet model to analyze 
data from mixtures of a lamellar phase and a triblock copolymer.60  
  
4.2. Materials and Methods  
Sample Preparation. The hm-chitosan polymer and the surfactant vesicles 
are identical to those used in Chapter 3. The hm-chitosan has a molecular weight 
around 200,000, and 2.5 mol% of its amines are substituted with n-dodecyl tails. All 
samples in this study were prepared in D2O (Cambridge Isotopes). Solutions of the 
hm-chitosan were made in 1% acetic acid. The vesicles were prepared by mixing 
solutions of the cationic surfactant, cetyl trimethylammonium tosylate (CTAT) and 
the anionic surfactant, sodium dodecyl benzene sulfonate (SDBS) in a weight ratio of 
70/30 (see Chapter 3 for further details). Vesicle-polymer mixtures of desired 
composition were obtained by mixing the stock solutions, followed by mild heat.  
 
Small-Angle Neutron Scattering (SANS). SANS measurements were made 




25°C in 2 mm quartz cells. The scattering spectra were corrected and placed on an 
absolute scale using calibration standards provided by NIST. The final reduced data is 
plotted as the radially-averaged, absolute intensity I versus the wave vector q. 
 
Cryo-Transmission Electron Microscopy (Cryo-TEM). Cryo-TEM studies 
were conducted at the University of Rhode Island using a JEOL 1200EX TEM. 
Samples were prepared as described in Section 2.4.4. Briefly, a drop of the sample 
was first placed on a holey carbon film supported on a TEM grid. A filter paper was 
then used to blot the drop, thus creating a thin film of the sample. The grid was then 
plunged into liquid ethane to rapidly vitrify the sample. Subsequently, the grid was 
transferred to a cold stage and maintained at –170°C in the TEM for observation.  
 
4.3. Results and Discussion  
4.3.1. SANS Data and Modeling 
We present SANS data for vesicle + hm-chitosan mixtures as a function of 
polymer concentration (Figure 4.2) and vesicle concentration (Figure 4.3). The data is 
presented for the absolute intensity I as a function of the scattering vector q. In Figure 
4.2, the vesicle concentration is held constant at 0.5%. Data are shown for the control 
sample (vesicles, no polymer) and for four different polymer concentrations. The 
curves are scaled by factors of 10 for easy identification. In Figure 4.3, the polymer 
concentration is held constant at 0.55%, while the vesicle concentration is varied from 
1.4% to 0.2%. The data in Figure 4.3 is shown unscaled – the curves are well-





Figure 4.2.  SANS data from vesicle-polymer mixtures as a function of the polymer
(hm-chitosan) concentration. The vesicle concentration is held constant at 0.5%. Data
is shown for the following polymer concentrations and data is shown for the polymer
concentration indicated. Successive curves are offset by factors of 10 for clarity.


























Figure 4.3. SANS data from vesicle-polymer mixtures as a function of the vesicle
concentration. The polymer (hm-chitosan) concentration is held constant at 0.55%.




















We now discuss the interpretation and modeling of these spectra. Consider 
first the control vesicles (Figure 4.2). In the dilute, non-interacting limit, the structure 
factor S(q) → 1 and we can model the data based on the form factor for unilamellar 
vesicles (ULVs) of radius R and bilayer thickness t, as described in Section 3.2.1. For 
thin bilayers, P(q) is given by eq 3.3, according to which I(q) should show a q−2 decay 
in the low q range. To account for polydispersity in the vesicle size, P(q) can be 
averaged over a Schultz distribution (eq 3.4–3.6), where the spread in vesicle sizes is 
measured in terms of a polydispersity index p. In Figure 4.2, the fit from the 
polydisperse ULV model is shown for the 0.5% vesicle solution. Note that the data 
follows a slope of –2 at low q. From the model, the average vesicle diameter D  is 
found to be 117 nm and the bilayer thickness t is 2.5 nm (see Table 4.1).  
 
Table 4.1. Parameters from SANS Modeling of Vesicle-Polymer Mixtures 
 
 
Next, we apply the polydisperse ULV model to vesicle-polymer mixtures in 
cases where the polymer:vesicle ratio is low. For the samples with 0.5% vesicles  + 
Concentrations Type of ULVs MLVs
Vesicles Polymer fit Avg. dia. Bilayr. thick. Polydisp. d-spacing Stack no. Caille param.
c v (%) c p (%) D (nm) t (nm) p d (nm) N η
0.5 0 ULV 117 2.5 0.25 - - -
0.5 0.1 ULV 53 2.5 0.30 - - -
0.5 0.3 ULV + MLV 52 2.5 0.30 25.0 2.5 0.50
0.5 0.55 ULV + MLV 40 2.5 0.24 18.4 2.6 0.45
0.5 0.8 ULV + MLV 39 2.5 0.27 17.5 3.0 0.40
0.2 0.55 ULV + MLV 39 2.5 0.21 19.9 3.0 0.29
0.5 0.55 ULV + MLV 45 2.5 0.25 19.9 2.4 0.40




0.1% polymer (Figure 4.2) and 1.4% vesicles + 0.55% polymer (Figure 4.3), the 
model yields a very good fit. From the data, we note that the addition of polymer 
reduces the vesicle size significantly (see Table 4.1). For example, adding 0.1% 
polymer to a 0.5% vesicle solution reduces the mean vesicle diameter D  from 117 
nm to 53 nm. Such a reduction in ULV size upon addition of polymer was inferred in 
Chapter 3 as well, and possible reasons were discussed earlier in Section 3.4.  
 
A further striking feature appears in the SANS data at higher polymer:vesicle 
ratios – viz., the emergence of two peaks at higher values of q, with the peak positions 
showing a “lamellar” spacing (first peak at q0, second at 2q0). We will show that the 
appearance of these high q peaks implies the formation of multilamellar vesicles 
(MLVs) with well-defined bilayer spacing. To model a mixed population of 
unilamellar vesicles (ULVs) and MLVs, we adopt the following procedure, illustrated 
in Figure 4.4. Two assumptions are inherent to our analysis: (a) the scattering from 
Figure 4.4. Typical modeling procedure for data corresponding to a mixture of
unilamellar (ULVs) and multilamellar vesicles (MLVs). The sample is a mixture of 0.5%
vesicles and 0.55% hm-chitosan. (a) The low q data is fit to a ULV model; (b) The
difference between the overall data and the ULV model is shown; (c) The structure factor
contribution to the curve in (b) is shown, and the line through this data is a fit to the































































the two types of vesicles is additive; and (b) the MLVs contribute to the scattering 
only on account of their bilayers. In other words, the MLVs are assumed to be so 
large that their overall size falls outside the range probed by SANS, which would 
allow us to neglect their contribution to the scattering at low q.  
 
The data shown in Figure 4.4a is for the sample with 0.5% vesicles + 0.3% 
polymer (from Figure 4.2). First, we apply the ULV model to the low-q data, ignoring 
the high-q peaks. Note that the fit is excellent at low-q, and the fit gives an average 
vesicle diameter of 52 nm (Table 4.1). Next, we subtract the ULV fit from the total 
intensity, and the resulting data is shown in Figure 4.4b. This data corresponds to the 
MLVs, and it closely resembles the scattering from a lamellar phase, with peaks at q0 
and 2q0. To model this data, we use the Nallet model, described earlier in this 
Chapter. The first step in this process is to calculate the bilayer form factor PB(q), 
which is given by eq 4.3 (the bilayer thickness t is assumed to be that of the ULVs). 
Then, we substitute the measured intensity I(q) and the calculated PB(q) into eq 4.2 to 
obtain the structure factor SB(q) for bilayers, which is normalized such that it 
asymptotically approaches 1. This data, shown in Figure 4.4c is then fit to the Nallet 
expression for SB(q) (eq 4.4), which is valid for a small number of bilayer stacks N. 
Note that the two parameters in this model are N and the Caillé parameter η (which is 
inversely related to the bilayer rigidity). The parameter d in eq 4.4 is the d-spacing of 
the bilayers, which is obtained directly from the peak position through the Bragg 





The above analysis was applied to all samples that showed high-q peaks, and 
corresponding values of N, η and d for these samples are given in Table 4.1. Also, 
combined fits incorporating both the ULV and MLV models are shown as solid lines 
through the I(q) data for each sample in Figures 4.2 and 4.3. Turning to Table 4.1, the 
first point to be noted is that the values of the stack number N range from 2.4 to 3. 
Note that the fractions represent linear combinations of the Nallet model for the 
integral values of N = 2 and 3. This implies that there are between two and three 
bilayers in each of our MLVs. The fact that peaks appear in SANS despite the small 
number of bilayers suggests that the bilayer spacing is tightly controlled. Further 
analysis of trends in d and h are discussed later. But first, we present data from 
cryo-TEM that corroborate the above SANS result of a small, finite number of 
bilayers per MLV. 
 
4.3.2. Cryo-TEM Data 
Typical images of our samples are shown in Figure 4.5. As expected, the 
control CTAT/SDBS sample shows polydisperse unilamellar vesicles, with diameters 
ranging from 60–100 nm. However, in the 0.5% vesicles + 0.3% hm-chitosan sample, 
two types of vesicles are seen. On the one hand, there are a number of unilamellar 
vesicles (ULVs) with diameters ranging from 20–60 nm. In addition, there are also 
larger bilamellar vesicles (BLVs), i.e., vesicles with two concentric bilayers, with 
diameters exceeding 100 nm. A similar mixture of ULVs and BLVs are seen in the 
three images of the 0.5% vesicles + 0.55% hm-chitosan sample. Again, the ULVs are 




seen to be elongated structures – this may be a result of the shear caused by the 
blotting during sample preparation.62 We should emphasize that mixtures of ULVs 
and BLVs were seen in virtually all images collected for this sample.  
Figure 4.5. Cryo-TEM images of the control vesicles (1) and vesicle-polymer
mixtures (2, 3). Samples 2 and 3 show a co-existence of unilamellar vesicles (which




 It is significant that the cryo-TEM images reinforce the conclusions obtained 
from SANS modeling. Specifically, the images confirm that (i) adding polymer 
reduces the sizes of the ULVs relative to the control vesicles; and (ii) at higher 
amounts, the polymer also induces the formation of bilamellar vesicles (BLVs) that 
co-exist with the ULVs (in rare instances, trilamellar vesicles were also seen). It also 
appears that the spacing between bilayers is identical in all the BLVs, confirming our 
hypothesis that this spacing must be tightly controlled to result in SANS peaks.  
Because of the shear associated with cryo-TEM sample preparation, a more 
quantitative comparison between the SANS and cryo-TEM data is not possible. 
Nevertheless, the qualitative agreement is encouraging.     
 
4.3.3. Analysis of Parameters from SANS Modeling  
 Further insight into our system can be obtained by discerning trends in the 
parameters obtained from SANS modeling. First, at a constant vesicle concentration 
of 0.5%, the d-spacing between the bilayers in the MLVs steadily decreases with 
increasing polymer concentration (Table 4.1). This point is underscored by the data in 
Figure 4.6a, where the bilayer structure factor SB(q) is plotted for three different 
polymer concentrations with the vesicle content being fixed at 0.5%. We note that the 
position of the primary lamellar peak (q0) moves to higher values of the wave vector 
as the polymer concentration is increased, indicating a decrease in the d-spacing. The 
plot in Figure 4.6b shows that the d-spacing decreases with polymer concentration 
according to a power law with a slope of approximately –1/3. The same trend in 





Next, we consider trends in the Caillé parameter η, which is observed to 
decrease systematically from around 0.8 to a plateau around 0.4 with increasing 
polymer:vesicle ratio (this is reflected as a slight sharpening of the SANS peaks). As 
shown by eq 4.5, η is an inverse measure of bilayer rigidity, and a decrease in η 
implies that the bilayers become more rigid. A similar increase in bilayer rigidity 
upon addition of associating polymer was found by Prud’homme et al.64 (see Section 
4.1.2). Table 4.1 also indicates a weak trend in the number of bilayer stacks N, which 
shows a small but systematic increase with increasing polymer:vesicle ratio, inching 
Figure 4.6. (a) Structure factors for three vesicle-polymer mixtures at a constant
vesicle concentration of 0.5% and varying hm-chitosan concentrations. Note that the
position of the primary peak moves to increasing wave vectors with increasing
polymer concentration, indicating a decrease in the d-spacing of the bilayers. (b) Plot
of the above d-spacings vs. polymer concentration. The d-spacing decreases
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closer to 3 at high ratios. Lastly, with regard to the size of the ULVs present, the 
average ULV diameter decreases to ca. 40 nm upon adding just a small amount of 
polymer and remains around this value with further polymer addition.  
 
4.3.4. Mechanism for Structural Transitions  
 Based on the above trends, we can put forward a tentative mechanism to 
explain the structural changes observed in our system. At low amounts of 
hm-chitosan, the vesicles tend to be decorated with a few hm-chitosan chains that 
have inserted some of their hydrophobes into the vesicle bilayers. These chains 
extend between adjacent vesicles and thereby connect and network these vesicles. On 
account of the embedded polymer chains, the bilayer becomes more rigid, which 
explains the decrease in η.61 In turn, the increase in bilayer rigidity serves to stabilize 
a higher curvature (smaller average size) for the vesicles, as has been observed by 
others.55 This can explain why the average vesicle size decreases. The same 
arguments were made earlier in Chapter 3.  
 
As more polymer is added, we suggest that a different scenario could occur. 
At this point, numerous polymer chains are likely to be bound to each vesicle, and 
there are possibly multiple connections between any two adjacent vesicles. The 
vesicle size cannot drop indefinitely (a limiting curvature is apparently reached when 
the diameter falls to ca. 40 nm). We suggest that instead, the polymer chains 
connecting adjacent ULVs induce their fusion into bilamellar structures (BLVs) 




concentration are depicted in Figure 4.7. Note that only a fraction of the ULVs fuse 
into BLVs, and the two types of structures co-exist. Each BLV is evidently formed 
from several smaller ULVs, with the polymer chains bridging the two bilayers.  
Figure 4.7. Schematic of the transitions occurring in vesicle morphology upon
addition of associating polymer. First, the size of ULVs decreases. At higher polymer
content, a few BLVs are formed that co-exist with the ULVs. For clarity, the polymer




It is worth emphasizing that at the onset of BLV formation, the d-spacing 
between the bilayers in the BLVs is comparable to the polymer’s radius of gyration 
(ca. 30 nm, see Chapter 3). With further polymer addition, the bilayer spacing 
systematically decreases – presumably, this is because bilayers that are covered by 
polymer chains to a greater extent experience an attractive “pull” towards each other. 
In other words, by bringing the bilayers closer, the polymer chains get to maximize 
the favorable contact between their hydrophobes and the confining bilayers, even if 
the chains must sacrifice some configurational entropy as they get squeezed a bit in 
the process.  
 
It is interesting to speculate on a possible connection with biological systems. 
Membranes that enclose cellular organelles are known to contain both lipids and 
amphiphilic macromolecules, such as membrane proteins.25 Interestingly, several 
organelles in eukaryotic cells are bilamellar, i.e., have a double membrane structure. 
These include the nucleus, the mitochondria, and the chloroplasts in plant cells. At the 
same time, these bilamellar organelles co-exist in a cell with numerous unilamellar 
(single membrane) organelles, such as lysosomes, endosomes, and Golgi bodies.25 
Why are only certain organelles bilamellar, and in those organelles, how is the 
spacing between the inner and outer membranes regulated? Although these issues are 
not fully understood at the moment, we can speculate that a key role might be played 
by amphiphilic macromolecules (e.g., membrane-bound proteins) in a similar way as 





4.3.5. Stability of Vesicle Co-Existence: Aging Effects 
 One last issue that we will touch on here is the issue of sample stability. The 
mechanism proposed above for the structural changes ascribed them to essentially 
thermodynamic forces (changes in bilayer rigidity, curvature, etc.). But can ULVs 
and BLVs indeed show a stable co-existence? Given time, will the ULVs aggregate 
and turn into BLVs, or into vesicles of an even higher lamellarity?   
 
To examine these issues, we have conducted SANS studies on vesicle-
polymer samples that were aged for more than one year (samples were stored at room 
temperature in the intervening period of time). Data for two such samples are shown 
in Figure 4.8, comparing the original and the aged responses (the data is shown 
unscaled). We note that the responses are approximately identical, with the aged 
sample having a slightly higher intensity. Modeling of the above data show that the 

































Figure 4.8. SANS data for two vesicle-polymer samples taken more than one year




regard to the MLVs, the d-spacing, stack number, and the Caillé parameter are 
approximately the same for both cases. Also, both the original and aged samples were 
visually seen to be clear, viscous fluids – i.e., there was no macroscopic phase 
separation over a one year period. The results suggest that a stable co-existence of 
vesicles of different lamellarity is indeed possible over significant periods of time, 
much like is observed for cellular organelles.   
 
4.4. Conclusions  
 We have shown in this Chapter that the addition of an associating biopolymer 
can cause changes in the size and morphology of unilamellar vesicles (ULVs). The 
polymer binds to vesicles, causing the bilayer to rigidify and in turn driving a 
decrease in the size of ULVs. At higher polymer:vesicle ratios, the polymer  induces 
the fusion of some ULVs to form bilamellar vesicles (BLVs). The co-existence of 
ULVs and BLVs in the sample leads to a striking pattern in SANS with multiple 
peaks, and modeling of this SANS data corroborates such a vesicular co-existence. 
Moreover, these structures have been directly visualized by cryo-TEM. Samples with 
co-existing ULVs and BLVs appear to be quite stable over more than a year. A 
possible connection is noted with the stable co-existence of uni- and bilamellar 






Vesicle-Biopolymer Capsules and 
Gels: Controlled Release Studies 
 
5.1. Introduction  
In Chapters 3 and 4, we have studied the microstructure and rheological 
properties of vesicle gels. As mentioned in Chapter 1, one of our motivations for 
studying these materials is due to their potential utility in drug delivery and other 
controlled release applications. Towards this end, we investigate in this Chapter the 
release kinetics of model hydrophilic dyes encapsulated in vesicle gels. In addition, 
we turn our attention to a second type of structure, viz. biopolymer capsules loaded 
with vesicles. Capsules are obtained by combining chitosan with an anionic 
biopolymer, and the loading of vesicles into these capsules results in a hybrid 
container-within-container structure. Again, we study the release kinetics of model 
dyes from these hybrid capsules. Also, to facilitate the use of capsules in targeted 
drug delivery, we make magnetic capsules containing magnetic nanoparticles. 
Additionally, we demonstrate a method to covalently attach antibodies to the capsule 
surface for biomolecular targeting to specific tissues. Altogether, the studies in this 
Chapter suggest that both vesicle gels and vesicle-loaded capsules could be useful in 





5.1.1. Drug Delivery From Vesicle Gels: Previous Work 
Vesicles are known for their ability to encapsulate desired chemicals, both 
hydrophilic moieties within their aqueous core, as well as hydrophobic moieties 
within their bilayer shell. These chemicals will tend to slowly leak out through the 
bilayer into the external fluid, thereby providing a convenient mechanism for 
sustained release. For drug delivery applications, vesicles are usually made from 
lipids (the term “liposome” is commonly used for lipid vesicles), since lipids tend to 
be naturally occurring and biocompatible components.  One problem with vesicle-
based drug delivery has been the rapid clearance of vesicles from the bloodstream by 
the reticuloendothelial system (RES).65 A partial solution to this problem is to coat 
the vesicles with polyethylene glycol (PEG), which is found to significantly enhance 
the circulation time of vesicles in blood (the exact mechanism for this is not well 
understood).8,65-68 Nevertheless, the limited stability of vesicles to external conditions 
such as pH, temperature or ionic strength still can cause the drug in the vesicles to be 
released too rapidly or at undesired sites within the bloodstream. There is hence a 
need to find mechanisms to stabilize vesicles.  
 
One possible mechanism to impart greater stability to vesicles is to embed 
them in a polymer gel matrix. In this case, there are no active connections between 
the polymer gel strands and the vesicles, unlike our vesicle gels in Chapters 3-4, 
where the vesicles play an active role as crosslinks in the gel network. The latter type 
of “active vesicle gel” has not been investigated for drug delivery to our knowledge. 




of researchers. The first report of vesicles in a gel was by Weiner et al. who 
embedded lipid vesicles containing hormones in a collagen matrix.69 They found that 
their hybrid gel prolonged the retention time of hormones. Following this study, 
vesicles have been encapsulated in gels of various kinds, including gels of 
biopolymers such as xanthan gum, chitosan, and carboxy-methylcellulose, as well as 
gels of synthetic polymers such as Carbopol.69-71 
 
Only a few commercial applications have been reported so far for gels 
containing embedded vesicles. The majority of these involve topical applications, 
with the vesicles serving to facilitate drug absorption into skin. Another application 
was recently described by Di Tizio et al., where vascular and urinary catheters were 
coated with a gel with embedded drug-containing vesicles. The authors showed that 
such a coating could minimize the risk of infection.72     
 
It is worthwhile to evaluate the factors necessary for the “vesicles in a gel” 
concept to be used in drug delivery. First, the vesicles should remain stable in the gel 
under physiological conditions (temperature of 37.6°C, pH of 7.4, ionic strength of 
0.25 M). Second, the polymer forming the gel should itself be biocompatible and 
biodegradable. Third, the gel stiffness and strength should be sufficiently high for the 
application of interest. If these conditions are met, the vesicles could indeed be 
“protected” by the gel matrix, and the release of encapsulated drug from within the 
vesicles could be prolonged due to the combination of transport resistances across the 




in Chapter 3-4, where vesicles are connected by associating biopolymer (hm-
chitosan) chains, have not been evaluated for drug delivery applications to our 
knowledge. Chitosan, as detailed earlier, is considered to be a biocompatible and 
biodegradable polymer. We will therefore evaluate vesicle gels formed using lipid 
vesicles and hm-chitosan as a controlled release matrix. 
 
5.1.2 Drug Delivery from Vesicle-Loaded Capsules: Previous Work 
Polymer capsules ranging in size from a few microns to several millimeters 
can be prepared by several methods such as solvent evaporation, coacervation, ionic 
gelation and spray drying.73,74 Capsules have been made from biopolymers such as 
chitosan, gelatin, agarose, and alginate, and synthetic polymers such as polylactic 
acid (PLA), polylactic–co-glycolic acid (PLGA), and polyvinyl alcohol (PVA). 
Structurally, capsules have a thin shell enclosing a water-filled interior. Drugs or 
macromolecules (proteins, hormones) can be encapsulated in the interior and 
delivered at a controlled rate.  
 
Capsules made from the polysaccharide, alginate have proven to be 
particularly popular, both for drug delivery applications as well as to immobilize cells 
for tissue engineering applications. These capsules are formed by ionic crosslinking, 
whereby a solution of sodium alginate is dropped into a solution of a divalent cation, 
typically calcium (Ca2+). In the process, the interface of the added drop is crosslinked 
by the calcium ions, resulting in an interfacial shell. The drug-release rate from 




the calcium ions. In vivo studies with alginate capsules have shown that they are 
biocompatible, non-toxic, and biodegradable over the long term.75 
 
Capsules can also be formed by polyelectrolyte complexation – a process 
that requires two biopolymers of opposite charge, or one biopolymer and a surfactant 
of opposite charge (the overall process is similar to that for alginate/Ca2+ above). For 
example, one could use sodium alginate, which is an anionic polymer, and either 
chitosan or poly-L-lysine (PLL), which are cationic polymers. To form the capsules, a 
solution of sodium alginate is added dropwise to a solution of chitosan. The contact 
between the oppositely charged polymers at the drop interface induces an electrostatic 
crosslinking, which gives rise to a polymer shell around the drop. In this way, 
capsules of given size (equal to the size of the generating drop) can be created readily 
by a simple, mild process (at room temperature, without using organic solvents), and 
it is straightforward to encapsulate drugs in the capsule in this method.  
 
Our interest lies in capsules with encapsulated vesicles. Note that capsules can 
protect vesicles from external stimuli, such as low or high pH, and from destruction 
by agents such as macrophages. Also, vesicles may extend the functionality of 
capsules, since they are more effective at encapsulating hydrophobic drugs (such as 
many anti-cancer formulations) than the capsules themselves. Finally, the 
combination of transport resistances from the vesicle bilayer and the capsule shell can 




The Langer group were the first to show that vesicles could be trapped in 
alginate microcapsules and that dye encapsulated in the vesicles could be released 
slowly under certain conditions.76,77 Subsequent studies from the same group showed 
that micro-encapsulated vesicles could extend the in vivo drug release time and 
minimize immune responses.78 The concept of “vesicles in capsules” has been used 
thereafter by other researchers.17,79,80 Cohen et al.79 encapsulated vesicles into 
alginate-PLL capsules. They found a higher release rate from anionic vesicles 
compared to cationic vesicles. The slower release rate in the latter case was attributed 
to binding of cationic vesicles with the anionic alginate chains in the capsule matrix.  
 
More recently, Dhoot et al.81 have studied the effect of crosslinking ions on 
release rates of fluorescein-isothiocyanate labeled bovine serum albumin (FITC-BSA) 
from vesicle-loaded alginate capsules. A rapid initial burst of the FITC-BSA protein 
was observed when alginate capsules were made with Ca2+, Al3+, and Ba2+. The 
release rate of the protein was found to differ based on the type of ions used in 
generating the capsules.    
 
Lastly, we wish to point out the recent report by Ramadas et al.82 who have 
used vesicle-loaded alginate-chitosan capsules for oral delivery of insulin. These 
capsules were able to deliver insulin to the intestine without undergoing degradation 
in the acidic environment of the stomach. This provides an example where the 





5.2. Materials and Methods  
Polymers. The chitosan and the hm-chitosan were identical to those used in 
Chapters 3 and 4 (from Sigma, molecular weight 200,000, degree of deacetylation 
80%). The graft density of n-dodecyl hydrophobes on the hm-chitosan was 2.5 mol%. 
Glycerol phosphate (GP) and glutaraldehyde (GA) (both from Aldrich) were used as 
physical crosslinking agents for the chitosan. The gelatin used to prepare capsules 
was purchased from Sigma and was of grade 300 bloom.  
 
Surfactant Vesicles. The surfactant vesicles were also the same as those 
studied in earlier chapters, and were prepared by mixing the cationic surfactant, cetyl 
trimethylammonium tosylate (CTAT) and the anionic surfactant, sodium dodecyl 
benzene sulfonate (SDBS) in a weight ratio of 70/30.  
 
Lipid Vesicles. The lipid, egg-yolk phosphatidyl choline (EPC) was 
purchased from Avanti Polar Lipids. Large unilamellar vesicles (LUVs) of the lipid 
were prepared according to the reverse-phase evaporation method.83 First, a lipid film 
was deposited on a vial by evaporation under a nitrogen atmosphere. The film was 
then redissolved in diethyl ether and an aqueous solution of 20 mM HEPES buffer 
(HEPES = 4-(2-hydroxyethyl)-1-piperazineethane-sulfonic acid; from Sigma) was 
added. The mixture was sonicated to get a homogeneous solution, and the diethyl 
ether was then removed under vacuum. This solution contains a polydisperse mixture 
of vesicles. To obtain vesicles of a given size, the above solution was extruded 
through a membrane filter of given pore size (typically 100 nm), which finally gives 




Encapsulating Dye in the Vesicles. The two fluorescent dyes, calcein and 6-
carboxy-fluorescein (CF) were obtained from Sigma. The chosen dye was added to 
the aqueous solution used in preparing either lipid or surfactant vesicles. A dye 
concentration of 100 mM was used with lipid vesicles and 0.5 mM with surfactant 
vesicles. In the process of forming vesicles, some of the dye remains encapsulated in 
the vesicles, while the majority of the dye diffuses freely outside the vesicles. The 
latter free dye was removed by size exclusion chromatography (SEC) using a 
Sephadex G-50 column (medium mesh, Amersham Bioscience).   
 
Preparation of Vesicle Gels. Vesicles with encapsulated dye were combined 
with hm-chitosan solution, and the mixture was mildly heated at 50°C for two hours, 
followed by centrifugation to remove bubbles.  
 
Preparation of Capsules and Vesicle-Loaded Capsules. The preparation of 
biopolymer capsules with hm-chitosan as the cationic biopolymer and gelatin as the 
anionic biopolymer is discussed in the Results section (5.3.3). The loading of vesicles 
into these capsules is also described in this section. 
 
Preparation of Magnetic Capsules. The γ-Fe2O3 particles used in preparing 
magnetic capsules were purchased from Alfa Aesar. Their size was specified to be 
32 ± 18 nm, and their average surface area was 42 m2 /g. The particles were dispersed 
at a concentration of ca. 0.1 to 0.2 wt% into the capsule forming solution using a 




to remove bubbles and then used immediately for preparing capsules. Further details 
on magnetic capsule preparation are described in Section 5.3.4. 
 
Preparation of Antibody-Functionalized Capsules. Fluorescein-labeled 
goat anti-mouse immunoglobulin (FL-anti-mouse-IgG), mouse IgG, and Alexa Fluor 
568  succinimidyl ester (AF) were purchased from Invitrogen. AF labeled-mouse IgG 
was synthesized using methods described by the dye supplier.84 Briefly, mouse IgG 
(2.5 mg/ml) was purified and brought to pH 8.5 using sodium bicarbonate buffer. 
Then, 1 mg of AF dissolved in 0.1 mL of dimethylsulfoxide (DMSO) was added and 
mixed for 1 h. The resulting AF-mouse-IgG was purified using a Sephadex G-25 
chromatography column to remove unreacted AF. AF-mouse-IgG was attached to 
capsules using glutaraldehyde (GA) as a bifunctional linker (details in Section 5.3.5). 
To image the antibody-coated capsules, fluorescence microscopy was used on a Leica 
MSFLIII microscope. For the FL dye, the excitation wavelength was fixed at 480 nm 
with a 40 nm bandwidth, and an emission cutoff filter at 510 nm was used. For the 
AF dye, the excitation wavelength was 560 nm with a 40 nm bandwidth, and an 
emission cutoff filter at 610 nm was used.   
 
Dye Release Studies. Dye release studies from vesicle gels and capsules are 
described in detail in the Results section. Phosphate-buffered saline (PBS) solution 
from Aldrich was used as the continuous medium. UV-Vis spectroscopy on a Varian 
Cary 50 spectrophotometer was used to monitor the dye concentration, with samples 
placed in 1 cm cuvettes. To disrupt vesicles (e.g., for determining the total dye 




5.3. Results  
5.3.1. Vesicle Gel Formation Using Lipid Vesicles  
Our initial studies in Chapter 3 used CTAT/SDBS surfactant vesicles, which 
are easy to prepare and work with as they are formed spontaneously and are 
indefinitely stable. For drug delivery applications, however, it is important to use 
vesicles made from natural lipids. But regardless of the type of vesicles (surfactant or 
lipid), we do observe gel formation upon adding hm-chitosan to the vesicles. For 
example, when EPC lipid vesicles at a concentration of 0.5% are mixed with a 0.7% 
hm-chitosan solution, we obtain a bluish gel that supports its own weight in an 
inverted vial. Dynamic rheological data (not shown) confirm that this sample is a gel 
with a plateau in the elastic modulus G′ at low frequencies. The modulus of lipid 
vesicle gels increases linearly with vesicle concentration, in much the same way as 
was found for surfactant vesicles (Figure 3.5, Chapter 3). Thus, vesicle gels seem to 
behave in a similar manner, whether they are formed from lipid or surfactant vesicles.   
 
5.3.2. Dye Release from Vesicle Gels  
We now describe dye release studies from vesicle gels. A CTAT/SDBS 
vesicle gel containing the dye, calcein inside the vesicles (no free dye) was placed in 
the bottom of a 3.5 mL vial, and the headspace above the gel was filled with 2.5 mL 
of a phosphate buffered saline (PBS) solution at pH 7.1 (Figure 5.1a). The PBS was 
used to simulate a physiological environment that would be encountered, for instance, 




time progresses, the dye from the gel diffuses into the supernatant, and the 
concentration of dye in this supernatant was continuously monitored by UV-Vis 
spectroscopy.  
 
We should point out that in Figure 5.1a, there is a clear interface between the 
vesicle gel and the PBS solution. This means that the vesicle gel is stable when placed 
in contact with the PBS solution, and does not “dissolve” away with time (thereby 
ensuring that we obtain a meaningful dye release experiment!). There are two issues 
to note here. First, these observations pertain to a “strong” vesicle gel, i.e., one that 
has a sufficiently high modulus to maintain its integrity. Second, the hm-chitosan 
itself is insoluble at pH 7.1 (note that the pH inside the vesicle gel starts less than  6.5 
due to the 1% acetic acid used to dissolve the chitosan initially), so it tends to form a 
sharp boundary when contacted with PBS.  
Figure 5.1 (a) Photograph showing the boundary between a PBS solution 
(supernatant) and a vesicle gel. (b) Calcein release profile from a surfactant vesicle 
gel. The lines are to guide the eye.
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We can now try to interpret the release profile shown in Figure 5.1b. The plot 
shows the cumulative dye release as a function of time. The total amount of dye 
encapsulated in the vesicles can be determined by analyzing the vesicle gel sample 
alone (for this measurement, the vesicles are typically lysed first by adding the 
detergent Triton X-100). The data show that even after 6000 min (100 hours), only 
about 40% of the dye in the vesicle gel has leaked out into the supernatant. At this 
point, we add some Triton X-100 to the supernatant. This molecule is expected to 
diffuse into the vesicle gel and begin to disrupt vesicles. If this were to occur, dye 
encapsulated in the vesicles would leak out, the gel would begin to degrade (since the 
vesicles are the crosslinks), and we should see an increase in dye release rate into the 
supernatant. Indeed, we observe precisely this in Figure 5.1b. The result here strongly 
suggests that the vesicles are indeed getting disrupted by the added Triton X-100. In 
turn, they imply that the vesicles remain intact throughout the dye release experiment.   
 
The above experiment suffers from the lack of an adequate control. In other 
words, we would like to compare dye release from one gel with vesicles and another 
gel without vesicles. We could thus specifically determine the effect of vesicles on 
dye release. However, such a comparison is not possible with the present system 
because the hm-chitosan alone does not form a gel even at very high concentrations. 
It is only in the presence of vesicles that a gel is formed, with the vesicles serving as 





An alternative therefore is to compare an hm-chitosan gel crosslinked by a 
different chemical moiety. For example, from the literature, mixtures of chitosan and 
glycerol phosphate (GP) are known to form gels at 37°C.85  We therefore set out to 
prepare two gels: one with hm-chitosan crosslinked with GP (1.8% hm-chitosan and 
3.6% GP) and the other with identical concentrations of hm-chitosan and GP and also 
containing EPC lipid vesicles (1.8% hm-chitosan, 3.6% GP, and 100 µL of a vesicle 
solution). Both gels were found to be clear and transparent at 37°C. Also, both gels 
were formulated to contain the same concentration of calcein dye – in the first gel, the 
dye was present in the gel matrix, whereas in the second case, the same amount of 




























Figure 5.2.  Calcein dye release profile for a control gel (1.8% hm-chitosan + 3.6%
GP) (red circles), and for a vesicle gel (1.8% hm-chitosan + 3.6% GP + 100 uL lipid




We are now in a position to make a clear-cut comparison of the “control” gel 
and the vesicle gel. The results are shown in Figure 5.2. As can be seen, the release 
from the vesicle gel is substantially slower than from the control gel. After 9000 min 
(150 hours), about 90% of the dye in the control gel has leaked out, whereas only 
about 30% of the dye in the vesicle gel has been released into the supernatant. This 
provides strong evidence for a prolonged release from the vesicle gel. In turn, it 
confirms that the presence of two transport barriers, one from the vesicle bilayer, and 
the other from the gel itself, will have a net effect of slowing down the release of 
diffusing small molecules.   
 
The results presented here are to be compared with a study conducted by 
Ruel-Gariepy et al.85, who studied gels of chitosan-GP containing lipid vesicles. 
These authors also reported a slower release when vesicles were present in their gels. 
According to them, the release rate could be controlled either by adjusting vesicle size 
or composition. For example, the presence of cholesterol in the vesicle formulation 
was shown to substantially slow the rates of dye leakage, because cholesterol reduces 
the bilayer permeability. Interestingly, the gels in the above study were all made with 
chitosan, whereas we have used hm-chitosan. Our own experiments (data not shown) 
reveal that the release rate is much slower with hm-chitosan than with chitosan for an 
equivalent vesicle-gel formulation. We can speculate that, in the hm-chitosan case, 
the presence of hydrophobes allows the chains to network the vesicles, which has two 
effects: one, it makes the gel more sturdy; and two, it further arrests the vesicles 




5.3.3. Preparation of Capsules Loaded with Vesicles  
 
We prepare capsules by electrostatic complexation of chitosan or hm-chitosan 
(cationic biopolymer) and gelatin (anionic biopolymer). As illustrated by Figure 5.3, 
the capsules are formed when a solution of the former is dropped into a solution of 
the latter. The shell of the capsule is created by strong electrostatic interactions 
between the oppositely charged species that lead to cross-linking at the drop interface 
while preserving the fluid nature of the capsule interior. Note that the capsule size is 
controlled by the drop size and the shell thickness is a function of the droplet soak 
time (incubation time). For the preliminary experiments in this dissertation, we 
typically made large capsules (~ 3-5 mm), and a soak time of about 5 min was found 
to be optimal in this case. Following the soak time, the capsules were removed and 
Figure 5.3. Preparation of vesicle-loaded capsules. A mixture of vesicles and cationic





placed into either a solution of deionized water or a PBS buffer solution. The capsules 
formed by this process were sturdy enough to allow gentle squeezing between the 
fingers. Also, they remained stable for long periods of time (several weeks at least). 
 
To make vesicle-containing capsules, the above procedure was modified. 
Instead of using just an hm-chitosan solution, a mixture of vesicles and hm-chitosan 
was added drop wise into a solution of gelatin. Note that mixtures of vesicles and hm-
chitosan are viscous solutions or gels with a bluish tint (Chapter 3). For these 
capsules, we typically used a polymer concentration between 0.3 and 0.55 wt% and a 
vesicle concentration of 1 wt% (10 mg/mL). Note from Figure 5.3 that the capsules 
formed by this procedure have a bluish tint, which is a visual indicator of the presence 
of vesicles. The vesicle containing capsules are quite stable and retain their original 
size and shape for several months.  
 
5.3.4. Preparation of Magnetic Capsules  
We now describe the preparation of magnetic capsules for use in targeted drug 
delivery. The idea here is that such capsules could be manipulated and guided by a 
magnetic field through the bloodstream to an area of interest, such as the location of a 
cancerous tumor. Magnetic nanoparticles (e.g., iron oxide) are used extensively in 
biomedical applications, such as for contrast enhancement in MRI86,87, and some iron 
oxides are approved by the Food & Drug Administration (FDA).88 We have used 
commercial ferrite (γ-Fe2O3) nanoparticles of ca. 32 nm size in our synthesis. A 




Figure 5.4. Magnetic capsules with encapsulated ferrite nanoparticles show their
magnetic properties in response to a bar magnet. (a) magnet placed near capsules in a
vial (b) magnet placed next to a tube in which the capsules are flowing along with the
fluid (water) from left to right.
 hm-chitosan  chitosan
Figure 5.5. Optical micrograph of magnetic capsules showing that the ferrite nano-
particles are well dispersed in capsules made with hm-chitosan (left), whereas they 
tend to form large aggregates in capsules made with chitosan (right). 
dropped into a solution of gelatin to form the magnetic capsules (soak time ~ 2 min). 
Note that the ferrite particles are embedded in the interior of the capsules. The 
resulting capsules respond to magnetic fields as depicted in Figure 5.4. Interestingly, 
we find that a dispersion of ferrite particles is much more stable in the presence of 
hm-chitosan than chitosan. Correspondingly, the ferrite particles in hm-chitosan 
based capsules are relatively well-dispersed, whereas in chitosan based capsules, the 




5.3.5. Conjugation of Antibodies to the Capsules  
In this section, we describe the synthesis of capsules with antibodies 
functionalized on their surface. Such capsules could be used for targeted drug 
delivery, for example to cancerous tumors.89-91 Cancerous tumors are known to 
overexpress particular antigens, which may thus be targeted for delivery of toxic 
drugs directly to the tumor and nowhere else.92 Such targeting has been attempted 
since 1975 and a number of such antibody-coated drug delivery vehicles have been 
approved by the FDA.93  
 
 
Here, to demonstrate a proof-of-concept, we study the attachment of 
fluorescently-labeled mouse IgG antibodies onto the surface of magnetic biopolymer 
capsules. For this synthesis (Figure 5.6), we exploit the fact that the capsules bear a 





number of amine groups from the chitosan. Glutaraldehyde is used as a bifunctional 
linker, which attaches to a amine from chitosan on the one hand and to an amine from 
the antibody on the other hand. As shown in Figure 5.6, the magnetic response of the 
capsules is used to separate them after each step in the process. Interestingly, the 
capsules originally have a brown color due to the ferrite nanoparticles, but after 
attaching the antibodies they become pink or red. This is a visual indication that 
antibodies are successfully attached on the capsule surface. 
 
To demonstrate successful functionalization, the antibody-bearing capsules 
were brought in contact with their corresponding antigen (FL-anti-mouse-IgG). After 
washing several times with buffer, the capsules were examined under fluorescence 
microscopy. Fluorescence images of these capsules simultaneously show both a red 
color (from the AF-mouse-IgG) and a green color (from the FL-anti-mouse-IgG) 
(Figure 5.7). This result confirms successful binding of antigen to antibodies on the 
capsule surface. The above procedure can be repeated with any desired antibody and 
would thus allow these capsules to be used for targeted drug delivery applications. 
 
 
Figure 5.7. Fluorescence microscopy shows that antibodies conjugated on the
surface of chitosan capsules are bound to antigens. The capsule shows a red color
(a) due to the AF-mouse-IgG antibodies on its surface, and simultaneously a non-






5.3.6. Dye Release from Vesicle-Loaded Capsules 
 
In this final section, we study dye release from vesicle-loaded capsules, with 
calcein serving as a model hydrophilic dye. Capsules for these studies were prepared 
as follows. First, a solution containing 1 wt% surfactant vesicles (70/30 mass ratio of 
CTAT/SDBS), 0.55 wt% hm-chitosan, and 0.5 mM calcein was prepared. After 
centrifuging to remove bubbles, drops of this solution were added into a 0.5 wt% 
Figure  5.8. Schematics of dye release experiments with vesicle-loaded biopolymer
capsules (a) Capsules are immersed in a bath of buffer and the dye concentration in
the bath is monitored. (b) The addition of Triton-X to the bath causes the vesicles in




solution of gelatin at pH around 12. The resulting capsules were removed and placed 
into a bath of PBS buffer (Figure 5.8a). In addition, a control experiment was 
conducted with capsules that were identical in all respects (same amounts of hm-
chitosan, gelatin and CF), except that they did not contain any vesicles. These control 
capsules were also placed in a second bath of PBS buffer. In each case, aliquots of 
buffer medium were  removed at different time intervals and analyzed by UV-Vis 
spectrometry to obtain the dye concentration as a function of time. 
 
Dye release profiles are shown in Figure 5.9 for both the control capsules as 
well as the vesicle-loaded capsules. Note that the release of dye is very rapid from the 
control capsules, with more than 80% of the dye being released within the first 200 
min. On the other hand, the release from vesicle-loaded capsules is much slower and 
only about 20% of the dye is released from these capsules even after 6000 min. At 
this point, we added the detergent Triton-X 100 to the bath. This detergent will 
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Figure 5.9. Dye release profiles from vesicle-loaded capsules (blue diamonds) and
the control (vesicle-free) capsules (red circles): (a) Results over a period of 10000
minutes. At the 6000 min mark, the detergent Triton-X 100 is added to each bath. (b)
Close-up of the release over the first 300 min, showing that most of the dye in the




diffuse through the capsule wall and destabilize the vesicles in the interior of the 
capsules, as shown in Figure 5.8b. As shown in the figure, the vesicles will be 
transformed into micelles, and thereby, the hydrophilic drug in the vesicles will be 
released within the capsules. This free dye will then leak out through the capsule shell 
and into the bath, thereby increasing the dye concentration. Indeed, our results 
(Figure 5.9a) show that the dye release accelerates after we add Triton-X 100 to the 
bath. These observations also confirm that the vesicles are present intact in the 
capsules before we add the detergent.   
 
To obtain further insight into the dye release behavior, we fit our release 
profiles to the empirical relation below, devised originally by Ritger and Peppas94: 





                                         
Here Mt is the cumulative amount of dye released into the bath at time t and M∞ is the 
total amount of dye that gets released. The variables in this equation are the power 
law index n and the constant k. The key variable is n, and the transport process is 
considered to be diffusion-controlled (Fickian transport) if n = 0.5. On the other hand, 
if 0.5 < n < 1, the process is deemed non-Fickian or anomalous transport, and finally 
if n = 1, it is referred to as zero-order or relaxation-controlled transport.95 This 
equation works well only in the initial portion of the release profiles, and so we have 
fit the data over the first 300 min (Figure 5.9b). The best-fit value of n for the control 
capsules was found to be 0.46, while for the vesicle-loaded capsules, n was 0.07. 




increased to 0.56. Note that a value close to 0.5 is found for both the control capsules 
as well as the vesicle-loaded capsules after vesicle destabilization. This result implies 
that in both these cases, the transport process is approximately diffusion-limited. The 
lower value of 0.07 for the vesicle-loaded capsules indicates a combination of 
transport barriers from the vesicle bilayer and from the capsule shell. Further 
experiments are under way to investigate these processes in more detail. In summary, 
the data show that vesicle-loaded capsules can be used for extended release of drugs 
or other molecules over periods of even weeks or months. The release rate can be 
accelerated if the vesicles inside the capsules are disrupted by an external stimulus. 
 
5.4. Conclusions  
In this Chapter, we have studied the release of dye from vesicle gels and 
vesicle-loaded capsules. Comparison of the dye release profiles from vesicle-loaded 
gels and capsules and those obtained from control gels and capsules reveals that the 
release rate is slowed down appreciably when vesicles are included in the 
formulation.  The results indicate that vesicle-containing gels and capsules could be 
used for the sustained delivery of small-molecular weight hydrophilic compounds. 
Additionally, in this chapter, we have described how to impart targeting capabilities 
to vesicle-loaded capsules. These include targeting by magnetic fields due to 
embedded magnetic ferrite nanoparticles, and targeting by biomolecular interactions 
via antibodies functionalized to the capsule surface. Thus, we envision applications 





Conclusions and Recommendations 
 
6.1. Conclusions  
We have studied the interactions between an associating biopolymer (hm-
chitosan) and vesicles (Chapters 3, 4) and the potential use of this system in drug 
delivery and controlled release applications (Chapter 5). We used two different types 
of vesicles: (1) surfactant vesicles made by mixing CTAT/SDBS in a 70/30 weight 
ratio; and (2) egg-yolk phosphatidylcholine (EPC) lipid vesicles. In both cases, we 
found that gels are formed when hm-chitosan is mixed with the vesicles. 
Interestingly, these gels have sufficient yield stresses such that they do not flow upon 
inverting their vials. The presence of vesicles in the gels was confirmed by visual 
observations (i.e., the bluish color of the gels) as well as by SANS and cryo-TEM 
experiments. Based on these findings, we postulated that the likely structure of these 
gels is a network of vesicles connected by associating polymer chains, with the 
hydrophobes on the polymer inserted into the vesicle bilayers.  
 
A more in-depth study using SANS and cryo-TEM (Chapter 4) revealed that 
upon addition of low amounts of the hm-chitosan, the vesicles re-organized into 
smaller entities so as to present more surface area for interaction with the polymer 




caused some of the originally unilamellar vesicles (ULVs) to fuse into bilamellar 
vesicles (BLVs). A co-existence of ULVs and BLVs was directly visualized by 
cryo-TEM. Moreover, this co-existence gave rise to a striking pattern in SANS with 
multiple peaks, and we were able to model this SANS data to corroborate such a 
vesicular co-existence. Also, SANS data taken on the same sample after more than a 
year indicated that the co-existence of ULVs and BLVs was a stable phenomenon.  
 
In Chapter 5, we conducted dye release studies using vesicle + hm-chitosan 
gels made using either surfactant vesicles or lipid vesicles (liposomes).  Vesicle gels 
retained their stability when placed in contact with a buffer (PBS) solution, which 
indicates that in vivo experiments are possible with these gels. Also, the release rate 
of dye from the gel into the buffer was significantly slower when the dye was 
encapsulated within the vesicles. This result suggested that the combination of 
transport resistances from the vesicle bilayer and the polymer matrix was effective in 
suppressing the release of dye. 
 
Chapter 5 also reported our experiments with a second type of structure, i.e., 
biopolymer capsules. We made capsules by contacting chitosan solution droplets with 
a solution of an anionic biopolymer or surfactant. Polyelectrolyte complexation leads 
to cross-linking at the drop interface while preserving fluidity inside the capsule. We 
then modified the capsule structure so as to make vesicle-loaded capsules. Dye 
release experiments again indicated that vesicle containing capsules released dye 




be accelerated if the disruption of vesicles could be triggered by external stimuli. 
These results were encouraging and they suggest that our hybrid vesicle-loaded 
capsules may be useful for sustained release of drugs or other molecules.   
 
Finally, in Chapter 5, we also investigated the preparation of capsules suitable 
for targeted drug release. The simplicity of the capsule forming process allowed us to 
incorporate ferrite nanoparticles together with the vesicles into the capsules. Capsules 
containing magnetic nanoparticles can be targeted to a desired location using a 
magnetic field. Also, we also showed how we can easily functionalize antibodies onto 
the capsule surface using a bifunctional linker such as glutaraldehyde. The antibodies 
permit the capsules to be used for biomolecular targeting, such as to corresponding 
antigens present on cancer cells. 
 
6.2. Recommendations for Future Work  
Study of the Interactions Between Liposomes and Associating Biopolymers  
In our study of the interactions between surfactant vesicles and hm-chitosan, 
SANS and cryo-TEM were proven to be valuable tools to understand the structure 
inside the resulting gels as well as the structural changes that vesicles undergo upon 
adding the polymer. It would be interesting to repeat the above SANS + cryo-TEM 
studies with lipid vesicles (liposomes) and hm-chitosan. For this future study, N-acyl 
chitosan should be used in addition to the hm-chitosan mentioned throughout this 
dissertation. N-acyl chitosan is known for its blood compatibility, biodegradability 




be worthwhile to study the interactions between liposomes and recently developed 
hydrophobically modified alginate.97 Alginate capsules have found widespread use 
and a variant of the capsules wherein vesicles are added may rapidly result in a 
commercially available product.   
  
In Vivo Studies with Vesicle Gels and Vesicle-Loaded Capsules 
In vivo studies of vesicle loaded gels and capsules can be done in the future. 
To avoid being ejected from the body through the RES, the capsule size can be 
further decreased using a new ink-jet technology98. Targetable capsules can be 
studied for the treatment of cancer. Targeting ability of magnetic capsules can be 
evaluated in vivo using magnetic resonance imaging (MRI). For biomolecular 
targeting, the capsule surface will have to be modified with the correct antigens that 
are known to be present on the exterior of tumor cells.  
 
For these future release studies, different types of lipid vesicles may be used. 
In particular, it would be interesting to work with hyperthermal liposomes, which can 
be induced to trigger by changing temperature.5  An example of such a temperature-
sensitive formulation is the mixture of mixture of the lipids DPPC (1,2-dipalmitoyl-
sn-glycero-3-phosphocholine), MPPC (1-palmitoyl-2-hydroxy-snglycero-3-phospho-
choline), and DSPE-PEG-2000 (1,2-distearoyl-snglycero-3-phosphoethanolamine-N-
polyethylene glycol 2000).5 Other possibilities for triggered release include that 
catalyzed by enzymes such as phospholipase A2 (this enzyme could be encapsulated 




Vesicle-loaded capsules can also be evaluated for the release of large 
macromolecules (e.g., proteins). For example, fluorescein isothiocyanate (FITC)-
labeled bovine serum albumin (BSA), FITC-horseradish peroxidase (HRP), and 
various growth factors including vascular endothelial growth factor (VEGF), basic 
fibroblast growth factor (bFGF), epidermal growth factor (EGF) and bone 
morphogenetic protein (BMP) can be encapsulated in vesicle-loaded capsules and 
their release profiles studied.  
 
Giant Vesicles  
Finally, it will be interesting to study the addition of hm-chitosan to giant 
vesicles. These vesicles can be prepared by the electroformation technique21 and they 
can be visualized using optical microscopy. The advantage of working with giant 
vesicles is that it may be possible to directly observe changes in vesicle structure 
when the hm-chitosan is added. For example, the addition of hm-chitosan may break 
large vesicles into smaller ones.99 Phenomena such as vesicle budding or pearling 
may also be induced by the polymer.100 The role of hydrophobes can be elucidated by 
comparing the hm-chitosan and the unmodified chitosan. Using fluorescent tags, it 
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